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Abstract 
Phthalate esters (phthalates) such as dibutylphthalate (DBP) are commonly used as 
plasticisers and pesticides in a variety of products such as children‟s plastic toys, food 
packaging, cosmetics, medical equipment (including surgical equipment), and acaricides. 
Because of their widespread use phthalates are ubiquitous environmental contaminants that 
humans are commonly exposed to. Phthalates are known endocrine-disrupting chemicals 
(EDCs) that are well known to cause male reproductive defects such as cryptorchidism 
(failed descent of the testes) and hypospadias (malformations in the urethra) in a range of 
different species if they are exposed in utero. They do this by reducing testosterone 
production in Leydig cells, which are the primary site of testosterone biosynthesis in the 
male. Because phthalates are dose-additive they are considered to share the same mechanism 
of toxicity. However, the details of phthalates mechanism of toxicity are not fully understood. 
The aim of this research was to investigate the effects of DBP on the steroidogenesis pathway 
using the cultured rat Leydig cell cancer line R2C as a Leydig cell model. R2C cells were 
exposed to a range of DBP concentrations (10 μg/mL, 5 μg/mL, 1 μg/mL, and 0.1 μg/mL) 
and their steroid hormone production was analysed using reverse phase HPLC. R2C cells did 
not synthesise testosterone at detectable levels. However, DBP exposure stimulated cortisol 
biosynthesis at all concentrations but caused no change in progesterone biosynthesis. This 
cortisol stimulation in Leydig cells has not been observed before. Because cortisol and 
testosterone compete for precursors an increase in cortisol synthesis could starve testosterone 
synthesis of precursors. On top of this it has been shown that glucocorticoids including 
cortisol have an adverse effect on Leydig cell development reducing steroid production and 
even causing apoptosis. This could explain how DBP and other phthalates can cause male 
developmental defects such as cryptorchidism and hypospadias.  
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Glossary 
Cryptorchidism: The failure of one or both of the testes to descend into the scrotum during 
early development.  Cryptorchidism is the most common birth defect regarding male 
genitalia. 
Hypospadias: A birth defect resulting in the malformation of the urethra resulting in 
abnormal placement of the urethral orifice. Instead of opening at the tip of the penis it is 
anywhere along the line anywhere between the tip and the intersect between the penis and 
scrotum. 
Androgens: The male sex hormones, responsible for the expression of male traits; comprises 
of 5 compounds, testosterone and 5α-dihydrotestosterone (DHT) are the primarily active 
hormones. 
Estrogens: The female sex hormones, responsible for the expression of female traits; 
comprises of 3 compounds (estrone, estriol, and 17β-estradiol), 17β-estradiol is the primarily 
active hormone. 
Corticosteroids: A class of chemicals that include steroid hormones produced in the adrenal 
cortex of vertebrates and analogues of these hormones synthesised in laboratories. 
Corticosteroids include the following steroid hormone groups: Glucocorticoids control 
carbohydrate, fat and protein metabolism as well as act as anti-inflammatories. Cortisol is the 
primary active glucocorticoid and is essential for a range of life functions. 
Mineralocorticoids control electrolyte and water levels. The primary mineralocorticoid is 
aldosterone which does this primarily by promoting Na
+
 retention in the kidney. 
Steroidogenesis: The entirety of the steroid biosynthetic metabolic pathway. 
 xv 
 
Small molecules such as steroid hormones and phthalates can exist in three forms when 
present in bodily fluids. The first is free in solution. This means the compound is in its 
original form or dissolved in the fluid and is bioavailable. The second is a protein bound 
form. In this state the compound is non-covalently bound to a carrier protein. The compound 
is sequestered in this state but will be readily released in response to equilibrium shifts in the 
fluid. The last is a conjugated form. In this state the compound will have a highly water 
soluble component such as a glucuronidate or sulphate covalently bound to it. Conjugated 
compounds are not bioavailable and are excreted. 
Endocrine system: Consists of all the hormone secreting glands in an organism as well as 
the secreted hormones and their activity. 
Hyperthyroidism: A condition where the thyroid gland produces excess amounts of thyroid 
hormones. 
Agonist: A compound that has the ability to bind to a cell‟s hormone receptor and induce a 
biological effect. 
Antagonist: A compound that can bind to a cell‟s hormone receptor but will not induce a 
biological response and will block the binding site preventing the endogenous hormone from 
binding, reducing the biological effect. 
Epigenetic effects: Changes in gene expression or cellular phenotype that are caused by 
mechanisms that are DNA independent (e.g. DNA methylation, and histone modification). 
Constitutive expression: A protein whose activity is constant and active and therefore is not 
regulated.
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1.1. The Biology and Metabolism of Leydig Cells 
1.1.1. Where are Androgens Made? A Brief History of Leydig cells 
Leydig cells were originally described by Franz von Leydig (1821-1908) in 1850 (Leydig 
1850). His seminal article was primarily a comparative study of male reproductive histology 
in different species. When Leydig observed the testis he noticed clusters of cells found 
consistently on blood vessels between the seminiferous tubules (the site of spermatogenesis) 
these cells were observed in multiple species and would come to be known as Leydig cells 
(Fig. 1.1).  
 
Figure 1.1: Illustrations of Leydig cells by Franz Leydig in his original 1850 article (Leydig 1850) Figures 
6 and 7 are the only ones of Leydig cells in his article. He described these as diagrams of “masses found 
between the seminiferous tubules and also found in the mediastinum of the cat testis (Figure 6) and the bat 
testis (Figure 7). (a) Small fat granules embedded in a soft ground substance. (b) The clear vesicular nuclei 
that are enclosed in the masses. (c) A blood vessel on which the masses are usually situated.” 
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In the late 19
th
 century, better specimen preparation methods were developed allowing further 
elucidation of the Leydig cell superstructure. For example, Friedrich Reinke (1862-1919) was 
able to observe crystalloids (crystal like structures) in human Leydig cells (Reinke 1896). 
During this period there were many suggestions as to what the function of the Leydig cell 
might be, but none of them considered they might have an endocrine function. The most 
popular of these, believed by Leydig himself, was that Leydig cells functioned as connective 
tissue cells. This was reinforced by a paper by David Hansemann (1858-1920) in 1895 
(Hansemann 1895) which discussed the reproductive cycle of marmots (Marmota marmota). 
He showed that the annual atrophy of the Leydig cells gave rise to fibroblast-like cells in the 
interstitial tissue. The then most popular hypothesis for Leydig cell function was that Leydig 
cells took up nutrients from circulation, processed them, and then passed them on to the 
seminiferous tubules (Fig. 1.2) to aid in spermatogenesis.  
 
Figure 1.2: Diagram of a testis and seminiferous tubule. Sperm are produced in the many seminiferous 
tubules and transported to the vas deferens. Between the seminiferous tubules interstitial tissue is 
present and Leydig cells are a part of this interstitial tissue. (By Ruth Lawson at 
http://commons.wikimedia.org/wiki/File:Anatomy_and_physiology_of_animals_The_testis_%26_a_ma
gnified_seminferous_tubule.jpg)  
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The first to strongly propose that Leydig cells had an endocrine function were Pol André 
Bouin (1870-1962) and Paul Ancel (1873-1961). Between 1897 and 1905 they conducted 
studies on Leydig cells and their endocrine role in regulating male secondary sexual 
characteristics. They published four major articles, one in 1903 (Bouin & Ancel 1903), two in 
1904 (Bouin & Ancel 1904; Ancel & Bouin 1904), and one in 1905 (Bouin & Ancel 1905). 
Their first article (Bouin & Ancel 1903) describes Leydig cells in the pig and other mammals 
in both infants and adults. Cells were described in both a normal state and after the animal 
had undergone a treatment-inducing blockage in the testicular excurrent ducts. They used 
these studies to argue that Leydig cells were glandular in nature and whilst they may supply 
some nutrients to the seminiferous tubules Leydig cells were independent of the seminiferous 
tubules, and that they appeared to constitute a gland of internal secretion that maintains 
sexual behaviour and male secondary sexual characteristics. The first 1904 article (Bouin & 
Ancel 1904) discusses evidence that neither Sertoli cells (cells responsible for nourishment of 
the sperm during spermatogenesis) or germ cells control male secondary sexual 
characteristics. The evidence obtained involved; the observation of individuals with 
cryptorchidism (impaired testicular descent during early development), blockage of the 
testicular excurrent ducts, compensatory testicular hypertrophy (rapid cell division) after 
partial castration, and observations on pathological conditions. These were often in 
combination. Bouin and Ancel found that in animals where the vas deferens (primary sperm 
transport duct) had been blocked, Leydig cells were more abundant and only Sertoli cells 
were present in the seminiferous tubules. The second 1904 article (Ancel & Bouin 1904) 
looked at evidence from embryos, immature animals and old animals, using similar 
methodology to the first 1904 paper. Leydig cells were abundant in late embryos whilst the 
seminiferous tubules were underdeveloped at this point, suggesting that Leydig cells control 
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the development of male characteristics as this is when the formation of the male tract and 
glands occur. 
Bouin and Ancel‟s 1905 article (Bouin & Ancel 1905) described Leydig cells in the horse 
over the course of the animal‟s life stages, from fetus until old age (A fetus of 45 cm, colts at 
4, 10, 11, 15, and 25 months of age, and stallions of 3, 8, and 20 years of age), and 
commented on testis size and Leydig cell population in the testes. The fetal horse testes were 
found to be surprisingly large (25-40 g per testis), and had a very well developed Leydig cell 
gland (the fetal interstitial gland). This gland was the main component of the testes as the 
seminiferous tubules had not fully formed at this stage in fetal development (Fig. 1.3). In 
colts at approximately 9-10 months, the testes were much smaller compared to the fetal testes 
due to atrophy of the fetal Leydig cells (FLCs). Leydig cells became well developed again in 
adult testes and lay between the active seminiferous tubules. In the testes of older animals 
less Leydig cells were found and testes were much smaller than in younger animals.  
Chapter 1 – Introduction 
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Bouin and Ancel‟s major hypothesis was that the general action of the testes on the 
individual, which was previously thought to be caused by the testes as a whole, was actually 
caused by the intersitial gland which was composed primarily of Leydig cells. The four 
principle pieces of evidence for this were: Firstly, that Leydig cells had the appearance of 
secretory cells having an epitheliod shape and prominent nucleus. They were also the only 
cell type in the testis with this morphology. Secondly, secondary male characteristics were 
preserved in individuals with regressed seminiferous tubules. Despite this regression, Leydig 
cells were still well developed, even undergoing severe hypertrophy. Thirdly, during 
embryonic development Leydig cells increase in number during the time when the male 
reproductive tract was forming; i.e the time at which the seminiferous tubules were 
Figure 1.3: First plate from Bouin and Ancel‟s 1905 article (Bouin & Ancel 1905) looking at testis 
from a 43 cm horse fetus (A) A low magnification view. Leydig cells fill most of the field. Small 
seminiferous tubules are seen in the lower left and upper right. (B) A higher magnification showing 
connective tissue (right) beside a seminiferous tubule (left). (C) Detailed Leydig cells from the same 
testis as A and B. 
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underdeveloped. And finally, Bouin and Ancels 1903 study (Bouin & Ancel 1903) showed 
that Leydig cells did not primarily function to supply the seminiferous tubules with nutrients. 
However, Bouin and Ancel‟s evidence was all circumstantial and no direct evidence of 
Leydig cells producing a male hormone would be obtained for another 50 years. This led to 
many arguments for and against Leydig cells secreting a key male hormone that controlled 
male secondary sexual characteristics. One key proponent of Bouin and Ancel‟s hypothesis 
was Eugen Stienach (1861-1944) who performed a series of studies between 1910 and 1920 
(Stienach 1910; Stienach 1911; Stienach 1912; Stienach 1920). His main methodology 
involved the castration of rats and Guinea pigs followed by the transplantation of the testis to 
some of the castrated individuals via tissue graft (usually to the inner abdominal wall). 
Individuals with succesful transplants were compared with castrated individuals with respect 
to their development of secondary male characteristics. Successful transplants resulted in 
secondary male characteristics developing with the concurrent development of a large 
number of Leydig cells in the grafts; indeed they accounted for most of the mass of the grafts. 
This suggests that the Leydig cells grew rapidly to supply the male hormones that were not 
currently present in the castrated animals. On the other hand, the seminiferous tubules 
underwent degeneration. This was indicated by the lack of germ cells present. This provided 
strong evidence for the hypothesis that Leydig cells were responsible for male secondary 
sexual characteristics. However, in the 1920s most testicular experts still considered the 
seminiferous tubules as the most likely source of male hormones. In the 1930s experts 
opinion began to slowly shift towards the Leydig cell secretion hypothesis. The first direct 
evidence of this hypothesis was the histochemical identification of 3β-hydroxysteroid 
dehydrogenase (3β-HSD) a key enzyme in the biosynthesis of steroid hormones (Fig. 1.4). 
This was shown histochemically using a tetrazolium salt, a dye that is soluble and colourless 
in its oxidised state but after reduction by 3β-HSD becomes blue and insoluble thus marking 
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the tissue site of active 3β-HSD (Fig. 1.5). This study was published in 1958 by Lee 
Wattenberg (Wattenberg 1958) where he used this technique on the adrenal cortex, ovary and 
testis. On the testis exposure it can be clearly seen that 3β-HSD is found in the intersitial 
tissue where Leydig cells reside (Fig. 1.6). 
Figure 1.4: Steroidogenesis pathway. Of particular note are the androgens, testosterone and 
dihydrotestosterone as they are involved in male embryological and pubertal development.  
3β-HSD=3β-hydroxysteroid dehydrogenase, 17β-HSD=17β-hydroxysteroid dehydrogenase, 
Scarb1=Scavenger receptor class B member 1, CYP=Cytochrome P450 
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Figure 1.5: Simplified reaction for the reduction of a tetrazolium molecule to a formazan 
molecule. Tetrazolium salts are soluble and colourless whereas formazan salts are blue and 
insoluble. One such salt (neotetrazolium) is specific to 3β-HSD. R groups vary between 
different salts (in neotetrazolium the R groups are benzene rings). 
Figure 1.6: Figure showing a section of rabbit testis histochemically stained for the steroidogenic 
enzyme 3β-HSD from Wattenberg (1958).This assay for 3β-HSD activity (dark stain) was the first 
direct evidence of Leydig cells as the source of testicular androgens. 
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To further support that Leydig cells were the site of steroidogenesis in the testis, a 
biochemical assay was developed in 1965 by Christensen and Mason (Christensen & Mason 
1965) which was based on the finding that seminiferous tubules could be separated from the 
interstitial tissue in rat testes. Both the interstitial tissue (contains Leydig cells) and the 
seminiferous tubules were cultured separately then exposed to [
14
C]-progesterone and their 
[
14
C]-steroidogenic products were measured. It was shown that the interstitial tissue produced 
approximately 13.5 times more 17α-hydroxyprogesterone, 7 times more androstenedione, and 
3.5 times more testosterone than seminiferous tubules; this proved that Leydig cells were the 
primary source of androgens in the testes. Later studies have shown that this was the case in 
other vertebrates (Pudney 1996). These two discoveries definitively proved the theory that 
the interstitial tissue of testes, mainly composed of Leydig cells, functions as a male 
hormone-producing gland.   
1.1.2. The Origin and Function of Leydig cells 
As previously discussed, Leydig cells synthesise a variety of growth factors and hormones, 
primarily androgens, that facilitate the expression of male traits and behaviours. There are 
now known to be two Leydig cell populations; FLCs synthesise androgens and growth factors 
during fetal and embryonic development, and adult Leydig cells (ALCs) synthesise 
androgens both during and after puberty. Both FLCs and ALCs share similar characteristics 
such as steroidogenic activity and regulation as well as expressing various markers e.g. the 
proteins Desert Hedgehog (Dhh) and platelet-derived growth factors (PDGF) (both of which 
are morphogens that induce the expression of early steroid biosynthetic enzymes). Their 
multiple similarities suggest that they could develop from the same origin and are just 
different stages of the Leydig cell developmental process. However, after treatment with 
ethane dimethanesulfonate, which selectively kills Leydig cells (Laskey et al. 1994), ALCs 
can rapidly repopulate the testis from progenitor cells whilst FLCs cannot (Davidoff et al. 
Chapter 1 – Introduction 
11 
 
2004). This suggests that FLCs and ALCs could be developmentally distinct steroidogenic 
populations. 
1.1.2.1. Fetal Leydig Cells 
FLCs first arise in the mesenchyme (undifferentiated connective tissue) of the developing 
testis around embryonic day 12.5 (E12.5) in the rat or the 7-8
th
 week of pregnancy in humans 
(this is shortly after testis cord formation). Their original developmental source remains 
unclear; however, three potential sources have been proposed. First, they originate from the 
adrenal-gonadal primordium. This theory is supported by the fact that the adrenal system, 
particularly the adrenal cortex, can also synthesise androgens and other steroid compounds. 
This suggests they are of a common origin (Byskov 1986). The transcription factor 
Steroidogenic Factor 1 (Sf1) has been identified in the adrenal-gonadal primordium and 
continues to be expressed in both the adrenal cortex and gonads once they have separated 
from one another (Hatano et al. 1996). Sf1 is essential for the development of steroid 
producing cells and the expression of steroidogenic enzymes (Ingraham et al. 1994). This 
finding also suggests that Leydig cells arise from the adrenal-gonadal primordium as Sf1 is 
essential for androgen production.  
Second, FLCs could originate from the neural crest. The expression of markers normally 
exclusive to cells derived from neural crest in both fetal and ALCs is evidence of this claim 
(Davidoff et al. 2002; Davidoff et al. 2004). However, two rat neural crest lineage tracing 
mouse lines were examined by Brennan et al. (Brennan et al. 2003) and showed no evidence 
of the neural crest contributing to the FLC population, suggesting that FLCs do not originate 
from the neural crest.  
Finally, FLCs could originate from the coelomic epithelium which encapsulates the gonad. 
The coelomic epithelium is Sf1 positive and during testis formation it rapidly proliferates 
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suggesting it may contribute cells, potentially FLCs, to the testes during its development. 
Indeed, cells derived from the coelomic epithelium can enter the gonads and differentiate into 
Sertoli cells (Karl & Capel 1998). This process could also be a source of FLCs.  
FLCs could come from one or more of these proposed sources and differentiate in the testis. 
Once FLCs begin to differentiate they show characteristic features of steroidogenically active 
cells, one such characteristic is a large smooth endoplasmic reticulum (which is the site of 
most steroidogenic enzymes) (Kerr & Knell 1988). After their initial differentiation they 
begin to proliferate rapidly. In rats by E17 there are 2.5 x 10
4
 FLCs per testis and by E21 
(immediately before birth) there are approximately 1 x 10
5 
FLCs per testis (A 4-fold increase 
in numbers) (Kerr & Knell 1988). However, it has been shown that in rats FLC numbers peak 
around E18 and then begin to steadily decline until the second week after birth (Lording & 
Kretser 1972). This decrease in FLC number has led to many theories about their 
developmental fate in adults. Some rat studies suggest that FLCs undergo degeneration 
(Lording & Kretser 1972; Kuopio & Tapanainen 1989), whilst others suggest that they 
transform into ALCs (Mendis-Handagama et al. 1998) or persist in the testis along with 
ALCs (Ariyaratne et al. 2000; Kerr & Knell 1988).  
FLCs are essential for three major processes; the development of the Wolffian duct, male 
external genitalia, and the descent of the testis. The Wolffian duct develops into the 
epididymis (storage site for newly formed sperm), the vas deferens (transports the sperm for 
ejaculation) and the seminal vesicles (produces seminal fluid). This process has been shown 
to be testosterone dependant (Jost 1953). Because Leydig cells are the primary source of 
androgens, FLCs are essential to this process. Further evidence that androgens are necessary 
is seen when inactivation of the androgen receptor results in a loss of the Wolffian duct in 
genetically male rats (Yeh et al. 2002) and humans (Brown 1995). Testosterone is produced 
by FLCs in the embryological genital tubercle (precursor to the male external genitalia) this is 
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then converted into 5α-dihydrotestosterone (DHT) by the enzyme 5α-reductase (Fig. 1.6) 
which is expressed in specific tissues. It is now known that DHT is the main factor 
responsible for developing the male genitalia not testosterone (Russell & Wilson 1994). FLCs 
also produce insulin-like factor 3 (INSL3) as well as testosterone and both of these are 
necessary for testes descent. INSL3 promotes transabdominal migration of the testes (Kubota 
et al. 2001). Testosterone also promotes the formation of the scrotum and is essential for 
testis descent (Hutson et al. 1997). Inactivation of the testosterone or INSL3 production 
pathways leads to cryptorchidism (Zimmermann et al. 1999; Adham et al. 2000) which 
provides further evidence that these factors are essential to this process.  
1.1.2.2. Adult Leydig Cells 
ALCs go through four main developmental stages; stem Leydig cells (SLCs) (the 
mesenchymal stem cell population that will eventually differentiate into ALCs), progenitor 
Leydig cells (PLCs), immature Leydig cells (ILCs), and finally ALCs. SLCs proliferate 
neonatally and were originally identified because they were present in large numbers in the 
testicular interstitium prior to ALC formation (Hardy et al. 1989). These stem cells are 
spindle shaped and do not express steroidogenic enzymes or the luteinizing hormone receptor 
(LH receptor) which are both characteristic of ALCs (Benton et al. 1995). PLCs arise on 
postnatal day 11-28 in rats. Like the SLCs they begin spindle shaped and do not express the 
LH receptor, but unlike SLCs they express steroidogenic enzymes such as 3β-HSD at low 
activities (Mendis-Handagama & Ariyaratne 2001). Over time, PLCs stop proliferating and 
enlarge becoming round in shape. They also begin to express more steroidogenic enzymes 
and at higher activities, but they lack 17β-hydroxysteroid dehydrogenase (17β-HSD) and so 
accumulate the testosterone precursor androstenedione (Mendis-Handagama & Ariyaratne 
2001). PLCs also have high activities of 5α-reductase and 3α-hydroxysteroid dehydrogenase 
which metabolise androstenedione preventing its secretion at elevated levels with respect to 
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ALCs and FLCs (Shan et al. 1993). PLCs continue to differentiate forming ILCs the second 
ALC intermediate. ILCs are most commonly seen in the testes between postnatal days 28-56 
in rats and stain heavily for 3β-HSD as well as having high LH receptor activity (all key 
characteristics of ALCs) (Codesal & Regadera 1990). ILCs are also much rounder than PLCs 
or SLCs due to their high smooth endoplasmic reticulum content. Another key characteristic 
that differentiates ILCs from other Leydig cells is their large number of cytoplasmic lipid 
droplets (Shan & Hardy 1992; Shan et al. 1993). These have a high esterified cholesterol 
content that can be readily converted to cholesterol, the precursor of steroid synthesis. These 
lipid droplets diminish when ALCs are formed (Shan & Hardy 1992; Shan et al. 1993). ILCs 
express 17β-HSD at higher activities by postnatal day 56 completing the androgen 
biosynthetic pathway and allowing the synthesis of testosterone (Ge & Hardy 1998). The 
ILCs undergo a final division before full ALC functionality develops on postnatal day 56 
(Hardy et al. 1989); cell division and growth come to an end at this stage. ALCs contain a 
large smooth endoplasmic reticulum (like ILCs), few lipid droplets (suggesting that the 
primary cholesterol source has shifted from the lipid droplets to cholesterol de novo synthesis 
and low density lipoprotein transport), high levels of steroidogenic activity, and secrete 
testosterone as their main androgen end product. ALCs also have far less 5α-reductase 
expression (Ge & Hardy 1998) allowing for production of testosterone without it being 
further metabolised. This secretion of androgens is essential for pubertal development during 
the ILC and ALC phases. Because ALCs do not divide, any damage resulting in loss of ALC 
numbers will be replenished by PLCs and ILCs differentiating into ALCs. However, after 
puberty PLC and ILC numbers start to decline. ALCs provide a constant level of testosterone 
during adult life maintaining fertility and male secondary sexual characteristics such as 
increased bone density. 
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1.1.3. Steroid Biosynthesis 
Steroid hormones have a wide variety of functions; from the stress response associated with 
cortisol to the sex determining testosterone and 17β-estradiol. The primary tissues that 
produce steroids are the testes (primarily produces androgens), the ovary (primarily produces 
estrogens), and the adrenal system (primarily produces corticosteroids). The steroidogenic 
pathway is catalysed by a range of enzymes and has many intermediates (Fig. 1.6). Each 
enzyme has a different role in the pathway (even though most enzymes can catalyse multiple 
steps in the pathway) and each one is tightly regulated by both tissue dependant processes 
and expression promoting factors. The key steroidogenic enzymes will be outlined below. 
1.1.3.1. Steroidogenic Acute Regulatory (StAR) Protein 
Steroidogenic acute regulatory (StAR) protein is responsible for the transport of cholesterol, 
the common substrate for all steroidogenesis, into the inner mitochondrial membrane from 
the outer mitochondrial membrane. This is the rate determining step of steroidogenesis 
(Stocco 1997) and because of this StAR is the  main regulation point of this pathway. StAR is 
present in all steroid-producing tissues (including the testes and adrenal system) and is 
essential for the production of normal levels of steroids. Mutations in the StAR gene result in 
congenital lipoid adrenal hyperplasia (Lin et al. 1995). This condition is potentially lethal and 
is characterised by extremely high levels of cholesterol in adrenal and testicular steroidogenic 
cells. Individuals who have this condition are unable to synthesise normal levels of steroids 
which results in build-up of cholesterol. The mechanism by which StAR transports 
cholesterol is unknown, but because StAR is rapidly imported and processed by the 
mitochondria it has been suggested that contact sites between the inner and outer 
mitochondrial membrane are formed and cholesterol was transported at these sites (Clark et 
al. 1994). This mechanism is tenable since similar mechanisms have been observed before 
Chapter 1 – Introduction 
16 
 
(Schwaiger et al. 1987). However, it is unlikely that this mechanism is essential as removal of 
62 amino acids from StAR‟s N-terminal region, including the mitochondrial binding 
sequence, does not change its ability to promote steroidogenesis (Arakane & Sugawara 
1996). On the other hand, removing the C-terminal region seems to remove StAR‟s ability to 
promote steroidogenesis and most mutations are seen in individuals with congenital lipoid 
adrenal hyperplasia (Miller 1997). Because StAR promotes such a crucial step in 
steroidogenesis, it is tightly regulated. Regulation of StAR is performed at a de novo 
synthesis level. Sf1 is an essential promoter for adrenal- and testes-specific expression of 
steroidogenic cytochromes P450. Steroidogenesis is up-regulated by the chronic stimulation 
of pituitary peptide hormones, LH in Leydig cells and the ovary, follicle-stimulating hormone 
(FSH) in the ovary as well as adrenocorticotropic hormone (ACTH) and angiotensin 2 in the 
adrenal system. The binding of these hormones to their receptors results in an increase in 
intracellular cyclic adenosine monophosphate (cAMP) concentration. This leads to 
phosphorylation of promoters of steroidogenic P450 enzymes, resulting in increased 
expression of StAR, and other steroidogenic enzymes, which leads to more cholesterol 
transport and consequently enhanced steroid biosynthesis (Gyles et al. 2001; Sugawara et al. 
2000).  
1.1.3.2. CYP11A (P450scc) 
The cytochrome P450, CYP11A, also known as cholesterol side chain cleavage enzyme, 
processes the first catalytic step in steroidogenesis, namely the formation of pregnenolone 
from cholesterol. It achieves this by hydoxylating two of cholesterols carbon atoms; C22, 
followed by C20. The C20-22 bond is then cleaved resulting in the products pregnenolone 
and Isocaproaldehyde (Payne & Hales 2004) (Fig. 1.6). Each oxidation step requires one 
molecule of O2 and one molecule of nicotinamide adenine dinucleotide phosphate (NADPH) 
(Burstein & Gut 1976). CYP11A is coded by a single gene (CYP11A) which has been 
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isolated from rats (Oonk et al. 1989) and humans (Chung et al. 1986) as well as other species 
(Venepally & Waterman 1995). CYP11A is located in the inner mitochondrial membrane 
where the electron transport proteins vital for oxidative catalysis are present. CYP11A is 
expressed throughout the adrenal cortex as well as Leydig cells, the ovary and the placenta 
(Oonk et al. 1989; Strauss et al. 1996; Ishimura & Fujita 1997; Payne & Youngblood 1995). 
Like all steroidogenic P450 enzymes, CYP11A requires the promoter Sf1 to be present 
allowing for expression of this enzyme to occur exclusively in steroidogenic tissues. Chronic 
LH stimulation is needed for optimal expression of CYP11A, like most steroidogenic 
protiens, CYP11A needs high intracellular cAMP concentration to increase expression, and 
indeed cAMP responsive regions have been found on CYP11A and CYP17 (Parker & 
Schimmer 1995; Youngblood & Payne 1992). 
1.1.3.3. CYP17 (P450c17) 
Like CYP11A, CYP17 is a cytochrome P450 enzyme. However, unlike CYP11A, it has two 
functionalities that can act on two different substrates. The first reaction catalysed is the 17α-
hydroxylation of pregnenalone or progesterone to produce 17α-hydroxypregnenalone or 17α-
hydroxyprogesterone respectively. The second catalytic activity is cleavage at the C17-20 
bond of these products to produce Dehydroepiandrosterone and Androstenedione respectively 
(Payne & Hales 2004) (Fig. 1.6). This step is essential to synthesise androgens and some 
corticosteroids. Like CYP11A, one O2 molecule and one NADPH molecule are necessary for 
each step (Nakajin et al. 1981). CYP17 is encoded by a single gene (CYP17) (Chung et al. 
1987). CYP17 is found in the endoplasmic reticulum where, like CYP11A in the 
mitochondria, the necessary proteins for catalysis are located. CYP17 is expressed in the 
adrenal gland, Leydig cells, and has limited expression in the ovaries (Endoh & Kristiansen 
1996; Sasano & Okamoto 1989; Pelletier et al. 2001). Like CYP11A, CYP17 is regulated by 
LH and internal cAMP concentration (Youngblood & Payne 1992). 
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1.1.3.4. CYP19 (Aromatase) 
CYP19 (aromatase) is also a cytochrome P450 enzyme, it catalyses the conversion of 
testostereone or androstenedione to estradiol or estrone respectively (Fig. 1.6). This is an 
essential step in the biosynthesis of estrogens. The mechanism of this reaction involves three 
catalytic steps; the first two are O2/NADPH-mediated oxidations of the C19 methyl group, 
the third step is an O2/NADPH-mediated elimination of the methyl group producing the 
steroid product and formic acid (Payne & Hales 2004). A single gene encodes CYP19 
(CYP19) (Simpson et al. 2002) and it is expressed in the ovary, placenta, and in Leydig cells 
(Kelch et al. 1972; Kamat et al. 2002; Simpson et al. 2002). Aromatase activity can be 
stimulated by FSH and human chorionic gonadotropin (pituitary peptide hormones) in rat 
Leydig cells (Valladares & Payne 1979; Rommerts et al. 1982). 
1.1.3.5. CYP21 (P450c21) 
CYP21 is a cytochrome P450 that catalyses the O2/NADPH-mediated hydroxylation of the 
C21 of progesterone or 17α-hydroxyprogesterone producing 11-deoxycortisol and 11-
deoxycortcosterone respectively (Fig. 1.6). This is an essential step in corticosteroid synthesis 
(Payne & Hales 2004). There are two genes, CYP21A and CYP21B, that encode CYP21; in 
humans, only CYP21B is active (White et al. 1986). CYP21 is located in the endoplasmic 
reticulum and is expressed exclusively in the adrenal cortex (Rice et al. 1990). Like other 
steroidogenic P450 enzymes, CYP21 is up-regulated by chronic stimulation by pituitary 
peptide hormones; specifically ACTH in the adrenal system (Waterman 1994). 
1.1.3.6. CYP11B1 
CYP11B1 is a cytochrome P450 that catalyses the 11β-hydroxylation of 11-
deoxycorticosterone and 11-deoxycortisol producing the glucocorticoids corticosterone and 
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cortisol respectively (Fig. 1.6). This reaction is O2/NADPH-mediated and occurs at the inner 
mitochondrial membrane where the required electron transport proteins are present (Payne & 
Hales 2004). CYP11B1 is essential to synthesise corticosteroids. It has two isoforms each 
encoded by a separate gene. CYP11B2, the duplicate gene, has slightly different functionality. 
These genes are closely linked and are only separated by approximately 40kb in humans 
(Lifton et al. 1992). Expression of CYP11B1 is exclusive to the adrenal cortex (Curnow & 
Tusie-Luna 1991). CYP11B1 expression is stimulated by angiotensin 2 and by K
+
 which 
increase intracellular Ca
2+
 concentration. Ca
2+
 acts through the same promoter sequences as 
the intracellular cAMP mechanism (Clyne et al. 1997). 
1.1.3.7. 3β-Hydroxysteroid Dehydrogenase (3β-HSD) 
3β-HSD is a membrane-bound enzyme that catalyses the conversion of the 3β-hydroxyl 
group of pregnenalone, 17α-hydroxypregnenalone, androstenediol or dehydroepiandrosterone 
to produce progesterone, 17α-hydroxyprogesterone, testosterone or androstenedione 
respectively (Payne & Hales 2004) (Fig. 1.6). This is achieved via two steps; first, the 
dehydrogenation of the 3β-equatorial hydroxyl group requiring nicotinamide adenine 
dinucleotide (NAD
+
) yielding a 3-keto intermediate and NADH. Second, the oxidation of 
NADH to isomerise the 3-keto intermediate forming a double bond between C4 and C5 
producing the 3-keto-steroid product (Thomas et al. 1995) (Fig. 1.6). 3β-HSD is vital for both 
androgen and corticosteroid synthesis. 3β-HSD has two isoforms in humans and six in mice, 
each of these are coded by distinct genes (Morissette & Rheaume 2008; Bain et al. 1993). 
Human 3β-HSD I is expressed in the placenta, skin, and breast tissue, whereas 3β-HSD II is 
expressed in the adrenal gland, ovary and testis (Kheaume et al. 1991; Simard & Durocher 
1996). This appears to be the same for the mouse 3β-HSD with isoform I being expressed in 
the adrenal system, ovary, and testes, whereas isoform VI has been observed in skin, 
placental tissue and testis (Simard & Durocher 1996). Human 3β-HSD II and mouse 3β-HSD 
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I seem to be regulated by Sf1 in a similar fashion to the other testis and adrenal specific 
steroidogenic cytochrome P450s (Leers-Sucheta et al. 1997; Clarke & Bain 1996). However, 
mouse isoform VI and human isoform I are regulated by two different promoters to regulate 
placental expression (Peng & Payne 2002). 
1.1.3.8. 17β-Hydroxysteroid Dehydrogenase (17β-HSD) 
17β-HSD is an essential enzyme in the synthesis of androgens and estrogens. Unlike the other 
enzymes discussed above, apart from CYP19, 17β-HSD is not involved in glucocorticoid or 
mineralocorticoid synthesis. It converts the substrates dehydroepiandrosterone, 
androstenedione and the estrogen estrone to androstenediol, testosterone, and estradiol 
respectively (Fig. 1.6). It does this by reduction of the 17-keto group utilising NADH. 17β-
HSD can be membrane bound or soluble (Payne & Hales 2004). Like 3β-HSD there are 
multiple isoforms of 17β-HSD; 11 have been identified. However, unlike 3β-HSD, there is 
little homology between isoforms (Adamski & Jakob 2001; Peltoketo, Luu-The, et al. 1999). 
Isoforms can differ in substrate specificity, tissue distribution, catalytic preferences (some 
isoforms can catalyse the reverse reaction with their particular substrate), subcellular 
localisation and mechanisms of regulation. Each isoform is synthesised by an exclusive gene. 
Tissue specificity of 17β-HSDs depends on the isoform, e.g. 17β-HSD1 and 17β-HSD7 are 
both found in the ovary and placenta (these two enzymes synthesise estradiol), whilst 17β-
HSD3 is expressed exclusively in the testes (this enzyme irreversibly synthesises 
testosterone). 17β-HSD1 and 17β-HSD7 are up-regulated by FSH and LH respectively, 
whilst 17β-HSD3 is up-regulated by gonadotropin stimulation during postnatal development 
and androgen action after puberty (Peltoketo, Nokelainen, et al. 1999; Baker et al. 1997). 
Again, control of this enzyme is crucial to cell function and is tightly controlled. 
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1.1.3.9. Steroid 5α-Reductase (5α-Reductase) 
Steroid 5α-reductase (5α-reductase) catalyses the 5α-reduction of the 3-keto C4-C5 double 
bond in various steroid substrates, either to remove them from the steroidogenesis pathway 
(e.g. 5α-dihydroprogesterone cannot proceed down the steroidogenesis pathway) or produce 
vital steroid products. Two such reactions are the conversion of testosterone to DHT or 
progesterone to 5α-dihydroprogesterone (Fig. 1.6). 5α-Reductase is membrane-bound and 
uses NADPH as an electron donor. Conversion of testosterone to DHT occurs in most 
androgen target tissues, including the testes (Ficher & Steinberger 1971). Two isoforms of 
5α-reductase have been identified. These two isoforms are coded by distinct genes which 
have been identified in humans and rats (Russell & Wilson 1994; Mahendroo & Russell 
1999). Whether or not a tissue expresses 5α-reductase will determine the primary androgen 
present in this tissue. If 5α-reductase is not expressed, testosterone (which diffuses across the 
membrane into the cytoplasm) is the main androgen stimulating male expression. If 5α-
reductase is expressed DHT, which is greater than 10 times more potent than testosterone 
(Deslypere & Young 1992), is the primary androgen stimulant. 
1.1.3.10. The Androgen Receptor 
As previously stated, testosterone and DHT are the key hormones involved in 
masculinization both during early development and at puberty. These hormones act through 
the androgen receptor (AR) (Heemers & Tindall 2007). The AR is expressed in a variety of 
tissues both reproductive and non-reproductive (Zouboulis et al. 2007). The AR is found 
primarily in the cytoplasm in its unbound state and is located in a complex with a variety of 
heat shock proteins and immunophilin chaperones. During androgen binding, the AR 
undergoes a conformational change and the composition of the protein complex changes 
allowing the AR to enter the nucleus and form active homodimers (Wilson & French 1976; 
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Heemers & Tindall 2007). This activated AR complex can then bind to specific DNA 
sequences known as androgen response elements. The complex will then either directly 
interact with the transcription preinitiation complex or recruit other proteins that have the 
capacity to do so (Wang et al. 2005; Heinlein & Chang 2002; Lee & Chang 2003; Heemers & 
Tindall 2007). This, in turn, induces expression of genes specific for male primary and 
secondary sexual characteristics. Testosterone, the primary androgen in the blood, and its 
derivative DHT can both diffuse into a target cell and bind to the AR. If the target cell 
expresses 5α-reductase, the primary binding androgen will be DHT if it does not express 5α-
reductase testosterone will be the primary binding androgen. DHT has a higher affinity for 
the AR and, consequently, its biological activity is up to 10 times that of testosterone 
(Deslypere & Young 1992). 
1.2. Phthalates and Endocrine Disruption 
1.2.1. The Endocrine System 
The endocrine system consists of all of the glands responsible for secreting hormones. Along 
with the nervous system, the endocrine system is responsible for a range of processes all of 
which are designed to maintain homeostasis. Hormones (unlike neurotransmitters) affect 
every tissue in the body via their secretion into the blood. There are three major hormone 
types (based on chemical structure) secreted by the endocrine system; they are as follows: 
Firstly, protein and peptide hormones are produced by a wide range of endocrine tissues. 
These molecules are usually synthesised in an inactive form and then are activated either 
through the removal of non-functional segments via proteolytic cleavage or via glycosylation 
of key residues prior to secretion (Smirnova 2000; Leblebicioglu et al. 2013). Protein and 
peptide hormones are composed of a variety of positive and negatively charged acidic and 
basic amino acids which result in the hormones overall physiological pH of 7.4. Because 
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water can interact with these charged amino acids protein and peptide hormones are 
hydrophilic and are easily transportable to tissues via the blood. However, this hydrophilicity 
makes it difficult for them to pass through the cell membrane. Because of this, the majority of 
the receptors associated with protein and peptide hormones are membrane bound and consist 
of an extracellular binding domain for the hormone and an intracellular domain which will 
cause an intracellular response after the hormone is bound (Smirnova 2000; Leblebicioglu et 
al. 2013). Due to their hydrophilicity protein and peptide hormones can easily be excreted 
without any modification. However, there are enzymes that will inactivate protein and 
peptide hormones to allow for the tight control of signal duration (Glass et al. 1969). 
Examples of protein and peptide hormones are: LH, FSH, adrenalcorticotropic hormone 
(these three stimulate steroid synthesis in different tissues), glucagon, and insulin (these two 
regulate blood glucose levels) to name a few (Leblebicioglu et al. 2013). 
Secondly, there are hormones that are derived from a single amino acid. Dopamine and 
epinephrine are amine hormones that are both derived from tyrosine (Kopin 1968) though 
amine hormones can also be derived from other amino acids. Amine hormones, like protein 
and peptide hormones, are hydrophilic and are freely soluble in the plasma. This means that, 
like protein and peptide hormones, amine hormones bind to the extracellular regions of 
membrane bound receptors. Amine hormones are broken down by monoamine oxidases to 
form hormonally inactive compounds (Kalgutkar et al. 2001). The thyroid hormones 
(thyroxine and triiodothyronine), like dopamine and epinephrine, are synthesised from 
tyrosine (Kinne et al. 2011). However, because they contain two nonpolar iodinated rings 
they are hydrophobic (Piehl et al. 2011). Because of this they do not dissolve in the plasma 
and thus they are transported on plasma carrier proteins. On the other hand, they can also 
either diffuse through the cell membrane or be transported through the membrane by 
transport proteins allowing them to interact with both surface receptors and intracellular 
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receptors (Leblebicioglu et al. 2013; Piehl et al. 2011). Thyroid hormones are firstly 
deiodinated and then are conjugated via glucuronidation or sulphation prior to excretion. 
Lastly, there are the steroid hormones which are all synthesised from the common precursor 
cholesterol (Gimpl et al. 2002). Because cholesterol is such a nonpolar, hydrophobic 
molecule steroids are also poorly soluble in water. Due to this hydrophobicity, like the 
thyroid hormones, steroids are reversibly bound to carrier proteins that transport them to their 
target tissues. Steroids can also bind to both extracellular receptors (such as estrogen receptor 
α) or move through the cell membrane via either diffusion or transport proteins allowing 
them to interact with intracellular receptors (such as the AR) (Nemere et al. 2003). Steroid 
hormones are conjugated by phase 1 and 2 metabolism producing hydrophilic glucuronide 
and sulphate conjugates allowing them to be excreted rapidly in water-based excretory fluid 
(e.g. urine). Steroids have a variety of functions some examples include: 17β-estradiol which 
is the primary estrogen responsible for female development (Simpson et al. 2002); 
testosterone and DHT which are the primary androgens responsible for male development 
(see section 1.2.2.1); cortisol which is involved in the stress response; and aldosterone which 
promotes Na
+
 uptake. 
Hormone production itself is also tightly regulated via a combination of feedback 
mechanisms to allow control of the synthesis, secretion and degradation of hormones (Fig. 
1.7). Hormones are also rapidly degraded to make sure hormonal signals have a very limited 
time scale. This is vital because hormones act at very low concentrations and thus a small 
increase or decrease in hormone activity will produce a significant biological effect. 
However, there are multiple chemicals that disrupt the synthesis, secretion, transport, binding, 
action, or degradation of hormones. A chemical that does this is known as an endocrine-
disrupting chemical (EDC). 
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1.2.2. Endocrine-Disrupting Chemicals and Reproductive Health 
An endocrine disruptor has been defined as “an exogenous substance or mixture that alters 
function(s) of the endocrine system and consequently causes adverse health effects in an 
intact organism, or its progeny, or (sub) populations” (WHO & UNEP 2013), this includes 
EDCs. EDCs can interfere with hormones in a number of ways, including hormone 
production, release, metabolism, and degradation as well as being able to mimic the 
hormones and interact with their receptors (Tabb & Blumberg 2006). EDCs could potentially 
target a whole range of metabolic processes (it has even been theorised that EDCs metabolic 
interference could contribute to the growing obesity rate (Baillie-Hamilton 2002)). However, 
due to multiple observations showing an increased incidence of hyperthyroidism in cats from 
1 in 1000 in the 1970s-80s to 21 in 1000 in the 1990s (Edinboro et al. 2004) (making 
hyperthyroidism the most common endocrine disease in small animal diagnoses) EDCs 
targeting the thyroid response are being investigated (Boas et al. 2006). Also, because 
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Figure 1.7: The generalised production, activity and degradation of a hormone. Note that only 
hydrophobic hormones will be bound to carriers. Hormone production and degradation are tightly 
controlled to ensure that the appropriate levels of hormone are in circulation (both in bound and 
unbound forms). 
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multiple reports have shown an increase in the number of reproductive disorders (such as the 
increased female infertility rate and decreased sperm count) in both adults and during 
embryonic development (for example the increased incidence of male developmental defects 
such as cryptorchidism (failed descent of the testes) and hypospadias (malformation of the 
urethra)) most EDC studies have focussed on the sex steroid hormones (Crain et al. 2008; 
Sharpe & Skakkebaek 2003).  
EDCs that influence the production, transportation and activity of the sex steroids 
(specifically 17β-estradiol and testosterone) can originate from a variety of sources including 
pesticides, plastics, fungicides, industrial by-products, and some are even synthesised by 
biological organisms (Cimafranca et al. 2004; Grün et al. 2006; Hoppe & Carey 2007; 
Akingbemi et al. 2007; Lee et al. 2008; Hines et al. 2009; Park et al. 2010; Casals-Casas & 
Desvergne 2011). Because of their widespread use/production EDCs are ubiquitous 
environmental contaminants. These compounds can act via three primary modes of action; 
mimicking the hormone and binding to the receptor providing a reduced hormone response 
(i.e. a receptor agonist), mimicking the steroid and binding to the receptor resulting in 
enzyme inhibition. Thus, making it unable to be accessed by the target hormone (i.e. a 
receptor antagonist), or altering steroid production by influencing the expression or activity 
of key enzymes in the steroidogenesis pathway (Fig. 1.8).  
A commonly observed mode of EDC action is binding of the EDC to a hormone receptor 
inducing the same response as the target hormone. A common class of EDCs that utilise this 
mechanism are the xenoestrogens which contain a number of compounds that bind to the 
estrogen receptors (ERs) ERα and ERβ (Casals-Casas & Desvergne 2011). Xenoestrogens 
can originate from natural sources such as the plant-produced phytoesterogens. We are 
constantly exposed to phytoestrogens through our diet. For example, the phytoestrogen 
genistein produced by soy. Anyone with a soy component in their diet will be regularly 
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exposed to genistein which will bind to the ERs and induce an estrogenic response (Kurzer & 
Xu 1997). However, these natural compounds have existed for as long as the plants they‟re 
derived from. The much more recent synthetic xenoestrogens have been the main cause for 
concern. Prime examples of synthestic xenoestrogens are plasticisers and monomers of 
polycarbonate plastics such as bisphenol A (BPA) which is commonly used as both. BPA is 
commonly found as a polymer in polycarbonate containers that are used to store food and 
drink. BPA can bleed into the food/drink and upon consumption will cause an estrogenic 
response. Studies have shown that one week of polycarbonate bottle use increases urinary 
BPA content by two thirds (Carwile et al. 2009) and BPA is known to cause estrogenic 
effects in humans such as precoucius puberty in girls (Howdeshell & Hotchkiss 1999; 
Krishnan & Stathis 1993). Xenoestrogens bind to one or both of the ERs causing unregulated 
expression of female traits. Drinking from cans prior to the removal of plastic internal lining 
has shown to cause a significant increase in BPA exposure (Matsumoto et al. 2002). 
Another method of EDCs‟ activity is similar to the first in that the EDCs still bind to the 
hormone receptor but instead of mimicking the hormone‟s response these compounds inhibit 
the receptor occupying its binding site preventing the hormone from activating the receptor. 
An example of an EDC that act via this mechanism is the anti-androgen fungicide 
vinclozolin. Vinclozolin is a commonly used fungicide in vineyards as well as fruit and 
vegetable plantations so we are regularly exposed via diet. However, the exposure levels the 
general population are exposed to are not considered to be significant. Farm workers on the 
other hand, are exposed to levels which could produce adverse effects (WPPR 1998). 
Vinclozolin has been shown to cause male developmental defects, such as hypospadias, by 
inhibition of AR-mediated gene activation (Wong et al. 1995; Kelce et al. 1994). Other anti-
androgens with this activity are the herbicide linuron and the fungicide procymidone 
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(Svechnikov et al. 2010). These compounds also cause increased incidences of reproductive 
defects such as hypospadias and cryptorchidism in animals (Gray et al. 2001).  
A third mechanism of  EDCs action is by disrupting the biosynthesis of hormones by 
interfering with key enzymes in their biosynthetic pathways. For example, some 
xenoestrogens can interfere with testosterone synthesis. Dichlorodiphenyldichloroethylene 
(DDE), a stable metabolite of the ubiquitous environmental contaminant 
dichlorodiphenyltrichloroethane (DDT); DDT‟s use is now restricted due to its long 
biodegradation time; has been shown to stimulate aromatase activity and act synergistically 
with FSH (a pituitary peptide hormone) to stimulate StAR and early pathway CYP activity in 
human granulosa cells (steroid producing cells located in the ovary) (Younglai et al. 2004; 
Whitehead & Rice 2006). Lindane, a pesticide that is still used, inhibits progesterone 
production in a dose dependant manner in mouse MA-10 cells (an immortalised mouse 
Leydig cell tumour line that can produce early steroids) (Walsh & Stocco 2000). It does this 
by decreasing internal cAMP stimulation of StAR thus preventing the movement of 
cholesterol to the inner mitochondrial membrane where the enzyme responsible for 
progesterone synthesis (CYP11A) is located. 
Any of the mechanisms of  EDCs action discussed above would result in an overall change in 
hormone activity (Fig. 1.8) and there are myriad EDCs that act on estrogen and androgen 
hormonal activity via these mechanisms. However, many EDCs use a combination of these 
methods to achieve the reproductive disorders seen in exposure studies. For example, DDE 
does not just upregulate StAR, CYP, and aromatase activity resulting in more free estrogens; 
it also acts as an anti-androgen and binds to the AR (Kelce et al. 1995). These two activities 
both reduce testosterone activity and increase estrogen activity and because activated ERα 
supresses Leydig cell testosterone production (Akingbemi 2003; Kalla et al. 1980) 
testosterone activity is further reduced. BPA also acts in a similar manner as it has been 
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shown to both upregulate aromatase (Nativelle-Serpentini et al. 2003) and antagonise the AR 
(Sohoni & Sumpter 1998). Because humans are exposed to multiple EDCs the combination 
of several of these compounds should be taken into consideration when discussing acceptable 
doses. Because multiple EDCs act via the same mechanism (e.g. xenoestrogens all act as 
estrogen receptor agonists) most combinations will have at least an additive effect. Some 
xenoestrogens even act synergistically on the ERs causing a higher estrogenic response than 
their individual responses combined (Arnold et al. 1997). On top of this, it is possible for 
EDCs to have a multigenerational effect. BPA is known to have an epigenetic effect via 
alterations of DNA methylation patterns resulting in changed gene expression over multiple 
generations (Dolinoy 2008). In utero exposure to the effects of these compounds could have 
an even greater impact on reproductive development. Increased exposure to synthetic EDCs 
explains the gradual increase in the incidence of reproductive defects such as decreased 
sperm motility, genital defects, and infertility due to their effects on estrogen and androgen 
activity. Therefore, it is important to understand the mechanisms underlying the action of 
these EDCs so appropriate regulatory steps can be put in place to decrease exposure to levels 
where no adverse effects occur. 
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1.2.3. The Toxicity of Phthalates 
Phthalate diesters (phthalates) are a class of chemical that are commonly used as plasticisers 
and pesticides in a variety of products such as children‟s plastic toys, food packaging, 
cosmetics, medical equipment (including surgical equipment), acaricides, and are also used as 
solvents for inks (Foster et al. 2000; Xiao-feng et al. 2009; Janjua et al. 2007; Carran & Shaw 
2012; Svechnikov et al. 2010). Phthalates are composed of a benzene ring with two esters 
groups ortho to each other, making them phthalic acid molecules with ester linkages instead 
of carboxylic acid moieties (Fig. 1.9). The two phthalates most commonly used are 
diethylhexylphthalate (DEHP) and dibutylphthalate (DBP). 
Because of their widespread use phthalates are ubiquitous environmental contaminants 
(Fromme et al. 2002) meaning that humans and wildlife are regularly exposed to multiple 
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Figure 1.8: EDCs potential methods of action on hormone activity. ► = Hormone mimics amplify 
the biological effects by binding to the hormone receptor. X = Receptor inhibitor prevents 
hormone binding decreasing biological effects. X = Synthesis inhibitors prevent biosynthesis of 
hormones meaning a lower free hormone concentration resulting in less receptor binding and less 
biological effects. ►= Synthesis promoter leading to increased free hormone concentration and 
increased receptor binding resulting in amplified biological effects. 
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phthalates on a daily basis. It has been estimated that the average adult in Denmark is 
exposed to DBP doses between 1.8-4.1 μg/kg body weight/day and that children between 1-6 
years old are exposed to 8 μg/kg body weight/day through their diet (EFSA 2005). There are 
also groups that are exposed to higher phthalate levels through occupational exposure. For 
example, Chinese construction workers that regularly work with DBP and DEHP had 
significantly higher levels of phthalate metabolites in their urine (DEHP metabolites are 100x 
more concentrated) when compared with construction workers that do not work with DBP 
and DEHP (Pan et al. 2006). Phthalates are known EDCs (Mankidy et al. 2013; Pant et al. 
2011) and are associated with male genital developmental disorders such as hypospadias and 
cryptorchidism in a wide range of animal species including frogs (Rana rugosa) (Ohtani et al. 
2000) and rats (Wolf et al. 1999; Parks et al. 2000). Exposure of pregnant rats to phthalates 
resulted in a host of developmental defects including cryptorchidism, hypospadias, and 
testicular cancer. For example, Mylchreest et al (1998) found that increased DBP exposure to 
pregnant dams induced male genital malformations and reduced anogenital distance (AGD) 
(a small AGD is associated with an increased incidence of cryptorchidism) in their offspring 
in a dose dependant manner. A similar study by Gray et al (2000) showed that multiple other 
phthalates also induced this effect (e.g. doses of 750mg/kg body weight/day of DEHP in 
pregnant rats induced a 82% male genital malformation rate in their offspring). 
 
 
Chapter 1 – Introduction 
32 
 
 
 
Phthalates are known to cause these reproductive defects by decreasing testosterone synthesis 
in a dose additive manner (Howdeshell et al. 2007; Howdeshell et al. 2008; Mylchreest et al. 
2002; Parks et al. 2000) as well as decreasing the expression of INSL3 (a key molecule 
needed for testes descent) in FLCs (resulting in decreased mRNA levels) (Wilson et al. 
2004). Because testosterone and INSL3 are key molecules in early male genital development 
this explains the defects seen in exposed rats. This means that phthalate‟s endocrine-
disrupting activity is achieved by disrupting hormone synthesis rather than interacting 
directly with the AR. The fact that phthalates toxicities are additive suggests that they act via 
a common mechanism of toxicity. This mechanism is not yet fully understood. 
When phthalates are absorbed into an animal they are rapidly metabolised by esterases 
forming a monoester metabolite (e.g. DBP is metabolised to monobutylphthalate (MBP)) 
(Fig. 1.10). These esterases are primarily located in the liver (Hanioka et al. 2012) but non-
specific esterases found throughout the body (including the Leydig cells) can also catalyse 
this process (Molenaar et al. 1986). MBP can then be further hydrolysed by esterases to form 
phthalic acid or it can be hydroxlated and/or glucuronidated by phase 1 and phase 2 
Figure 1.9:  The general structure of a phthalate and the structure of phthalic acid. Both have a 
benzene ring with two side chains ortho of each other. In phthalic acid these side chains are 
carboxylic acid moieties. In phthalates these are ester linkages. The R group attached to these 
ester linkages defines which specific phthalate the molecule is e.g.  
Dibutylphthalate (DBP); R = CH2CH2CH2CH3  
Diethylhexylphthalate (DEHP); R = CH2CH(CH2)2CH2CH2CH2CH3 
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metabolism and excreted (Fig. 1.10). The first step in the DBPs in vivo metabolic pathway 
occurs very rapidly. In rats dosed with 100 mg/kg [
14
C]-DBP no DBP was detected in the 
plasma or urine. MBP and MBP glucuronide however were the two major DBP metabolites 
found in both urine and serum within two hours of administration (Fennell et al. 2004). 
Because phthalate monoesters are the main active metabolites in vivo, it is considered that 
they are the molecules that caused their respective phthalate‟s endocrine-disrupting activity. 
To support this, multiple phthalate monoesters, including MBP and monoethylhexylphthalate 
(MEHP) (DEHP‟s monoester metabolite), have been shown to decrease testosterone 
production in a dose dependant manner in MA-10 cells (Clewell et al. 2010).
 
 
 
Figure 1.10: The metabolism of DBP in mammals. The formation of MBP and phthalic acid is 
catalysed by esterases. MBP can also enter phase 1 metabolism to produced hydroxylated 
products these will then be glucuronidated by phase 2 metabolism along with MBP. 
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Several theories have been proposed for phthalates mechanism of toxicity. One such 
mechanism is the direct inhibition of key steroidogenic enzymes. Yuan et al (2012) tested this 
by isolating human and rat 3β-HSD and 17β-HSD and ran a kinetic analysis of these enzymes 
in response to various phthalates and their monoester metabolites. They found that whilst 
some phthalates caused competitive inhibition with respect to the steroid precursor the 
monoesters did not have any significant effect on catalysis (Yuan et al. 2012).  
A recent study suggested that phthalates‟ effects are mediated by increasing the levels of 
reactive oxygen species (ROS) Leydig cells are exposed to. They reported that at low doses 
MEHP stimulated steroidogenesis and increased the expression of StAR and other key 
steroidogenic enzymes. But, at high MEHP doses the oxidative stress caused by the increased 
presence of ROS caused a decrease in the expression of steroidogenic enzymes (StAR, 
CYP11A, 3β-HSD, and 17β-HSD) and therefore caused a decrease in testosterone synthesis 
(Zhao et al. 2012). 
Another proposed mechanism of phthalate toxicity is via the suppression of early 
steroidogenic enzyme expression. Clewell et al (2010) determined that both phthalate diesters 
and monoesters inhibited LH stimulation in mouse MA-10 Leydig cells. This resulted in 
decreased expression of a number of key steroidogenic enzymes including StAR, CYP11A, 
and CYP17 leading to decreased testosterone synthesis (Clewell et al. 2010). Other studies 
have also shown decreases in steroidogenic enzymes including 3β-HSD, StAR and CYP17 in 
the testis of rats exposed in utero (Lehmann et al. 2004). However, another study suggests 
that phthalates (specifically DBP) caused an increase in serum glucocorticoids (Xiao-feng et 
al. 2009); glucocorticoids would then bind to the glucocorticoid receptor causing the same 
down-regulation as seen in the Clewell et al (2010) and Lehmann et al (2004) studies. 
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On top of these proposed mechanisms recent studies have shown that phthalates (specifically 
DBP) may have a multigenerational effect. The children of New Zealand male soldiers 
exposed to high levels of DBP used as an acaricide (to kill Trombiculid mites that carry bush 
typhus) had a higher incidence of the male genital defects, cryptorchidism and hypospadias 
than the general population (Carran & Shaw 2012; Carran & Shaw 2010). The incidences 
reported by Carran and Shaw (2012) have been disputed, but it is accepted that there is a 
significant difference between the exposed soldier‟s children and the general population 
(Elwood & Borman 2012). This suggests that the toxicity of phthalates might be inherited 
due to an epigenetic effect that could be passed to the next generation via sperm. This has 
been seen in BPA‟s mechanism of toxicity which acts by altering DNA methylation patterns 
(i.e. epigenetically); therefore, an effect such as this could be possible. However, the majority 
of studies look at the exposure of pregnant rats and so reflect in utero exposure and not 
multigenerational effects. The closest to studying the epigenetic effects produced by 
phthalates was the exposure of rats to a combination of DBP, DEHP, and BPA, an increased 
incidence of testicular disease was seen in both the F1 and F3 generations (Manikkam et al. 
2013). However, whether phthalates contributed to this multigenerational effect is unknown. 
In order to further understand the biochemical mechanisms of phthalates‟ effects on male 
development, an understanding of the impact of phthalates on steroidogenesis in Leydig cells 
is necessary. 
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1.3. Research Objectives  
The aim of this research is to investigate the effects of DBP on the steroidogenesis pathway 
in the cultured rat Leydig cell cancer line R2C. 
This aim will be achieved through the following research objectives: 
1. To develop, and characterise the R2C and LC-540 Leydig cell culture systems and 
their steroidogenic biochemistry. 
2. To develop an analytical protocol that can both detect and quantify selected steroids 
secreted by cell cultures. 
3. To collect, analyse, and assess any changes in steroid levels produced by R2C cells 
exposed to varying concentrations of DBP using the developed analytical method. 
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2.1. Materials 
2.1.1. Chemicals 
All chemicals used were of general laboratory grade except: 
 Dibutyl phthalate (Sigma-Aldrich New Zealand Ltd, Manukau City, New Zealand) 
 Benzyl penicillin (Sigma-Aldrich New Zealand Ltd) 
 Streptomycin sulphate (Sigma-Aldrich New Zealand Ltd) 
 Ground dextran coated charcoal (Sigma-Aldrich New Zealand Ltd) 
 Trypan blue (Sigma-Aldrich New Zealand Ltd)  
 High performance liquid chromatography (HPLC) grade Acetonitrile (Acetonitrile 
gradient grade for liquid chromatography, Merck Millipore, Manukau City, New 
Zealand) 
 Analytical grade methanol (ECP ltd, Auckland, New Zealand) 
 Analytical grade diethylether (ECP ltd) 
 Synthesis grade trifluoroacetic acid (Scharlau, Barcelona, Spain) 
 MilliQ water was prepared using Q-Guard 1 purification pack (Merck Millipore) the 
water used had a resistance of 18.2 MΩ/cm. 
2.1.2. Biological products 
 Phenol red-free MEM powder (Sigma-Aldrich New Zealand Ltd) 
 Phosphate buffered saline (Sigma-Aldrich New Zealand Ltd) 
 Fetal bovine serum (Life Technologies, Auckland, New Zealand; Catalogue number 
10091-148) 
 Eagle‟s Minimum Essential Medium (Life Technologies) 
 TrypLE express (Life Technologies) 
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 Trypsin powder (Becton Dickinson, Auckland, New Zealand) 
 R2C rat Leydig cells (American Type Culture Collection (ATCC), Manassas, USA; 
ATCC number CCL-97) 
 LC-540 rat Leydig cells (American Type Culture Collection (ATCC); ATCC number 
CCL-43) 
2.1.3. Equipment 
 T-75 sterile culture flask (Sigma-Aldrich New Zealand Ltd) 
 Sterile filter (Steritop-GP, 0.22 µm, polyethersulfone, 500 mL 45 mm Merck 
Millipore) 
 Laminar flow cabinet (Cytoguard CG2000 series, model CGA-180, Clyde Apac, 
Sydney, Australia) 
 Inverted microscope (CKX41, Olympus, Melbourne, Australia) 
 Non sterile syringe filter (7.5mm non-sterile PTFE hydrophobic filter, Thermo Fisher 
Scientific, Melbourne, Australia) 
 Dionex brand HPLC system (P680 HPLC pump, automated sample injector ASI-100, 
thermostated column compartment TCC-100, Thermo Fisher Scientific) 
 Centrifuge (multifuge 1 S-R, Heraeus, Hanau, Germany) 
2.2. Cell Culture 
Cell culture procedures were developed in collaboration with my MSc student colleague 
Kristie Webber. This section represents joint work. 
 
 
Chapter 2 – Materials and Methods 
40 
 
2.2.1. Culture Media Preparation 
2.2.1.1. Heat Inactivation of Fetal Bovine Serum (FBS) 
The heat inactivation procedure developed by the Alliance for Cellular Signalling (Davis & 
Hsueh 2002) was used as follows: 
A 500mL bottle of fetal bovine serum (FBS) was taken from storage at -20  C and thawed 
overnight at 4  C, followed by gentle warming in a 37  C water bath making sure the water 
level was above the serum level in the bottle. The serum was gently mixed by inversion to 
ensure a uniform temperature throughout. Following thawing the serum was incubated for an 
additional 15min to achieve a final serum temperature of 37  C. The temperature of the water 
bath was raised to 56  C and the serum was allowed to warm to 56  C over 35 min. During this 
time the serum was gently inverted every 10 min. When the serum temperature was at 56  C it 
was incubated for a further 30min and the bottle was gently inverted every 10 min. The 
serum was then removed and cooled to room temp (30min). Serum (100 mL for 10% 
medium, 175 mL for 17.5% medium) was transferred to 200 mL sterile Schott bottles and 
stored at -20  C. 
2.2.1.2. Preparation of Phosphate Buffered Saline (PBS) 
MilliQ water (900 mL) was added to a 1L Schott bottle. One bottle of phosphate buffered 
saline (PBS) powder (9.6 g) was added to the PBS in the Schott bottle with continuous 
swirling of the liquid. A small amount (approx. 5 mL) of milliQ water was used to rinse any 
remaining PBS powder out of its original bottle and added to the Schott bottle. The pH of the 
PBS was adjusted to 7.4 using 1M HCL or 1 M NaOH. The resulting solution was made up 
to 1 L with MilliQ water. The PBS was redistributed into 100-200 mL aliquots and 
autoclaved (see section 2.2.1.5.1.). After autoclaving it was stored at 4  C. 
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2.2.1.3. Serum Stripping Process 
A solution containing 0.3 g/L MgCl₂(H₂O)6, 85.6 g/L sucrose, 2.4 g/L 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) in 1 L MilliQ water was divided (50 mL aliquots) 
into 50 mL plastic centrifuge tubes. Ground dextran coated charcoal (127 mg) was added to 
each and the centrifuge tube aliquots were inverted 10 times to allow even distribution of the 
charcoal. They were incubated at 4  C for 24 hours. The solution was centrifuged at 500 xg for 
10 min and the supernatant was poured off and 50 mL of inactivated FBS was added to the 
charcoal pellet in each centrifuge tube. The tubes were inverted 10 times and incubated for 24 
hours at 4  C. The solution was centrifuged at 1700 xg for 10 min and the stripped FBS was 
decanted into 200 mL Schott bottles in aliquots (100 mL for 10% medium, 175 mL for 17.5% 
medium) and stored at -20  C (Blom et al. 1998). 
2.2.1.4. Preparation of Penicillin and Streptomycin Solutions 
Benzyl penicillin (3 g) and streptomycin sulphate (2.8 g) was added to 100 mL MilliQ water 
and stirred overnight (magnetic stirrer) to completely dissolve the antibiotics. The solution 
was filtered into 5 mL aliquots using a sterile filter. The aliquots were stored at -4  C. 
2.2.1.5. Sterilisation of Glassware 
2.2.1.5.1. Autoclaving 
Glassware and pipette tips were autoclaved at 121  C, 15 psi for 20mins.  
2.2.1.5.2. Use of 70% v/v Ethanol (aq) Spray 
Glassware and metal instruments were sterilised by spraying with an aerosol of 70% (v/v) 
ethanol (aq) before transferring to a laminar flow cabinet. 
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2.2.1.5.3. Maintaining Sterility within the Laminar Flow Cabinet 
All sterile procedures were carried out in a laminar flow cabinet. The internal surfaces of the 
cabinet were pre-sterilised by exposure to germicidal UV light (254 nm for 2 hours). 
Immediately prior to use they were sprayed with 70% v/v ethanol (aq) aerosol. 
2.2.1.6. Preparation of Eagle‟s Minimum Essential Medium (MEM) Containing 17.5% FBS 
Heat inactivated FBS (see section 2.2.1.1.) (175 mL, stored at -20  C) was defrosted at 37  C in 
a water bath (15-20 min). Two 500 mL bottles of MEM, two 5 mL vials of pre-prepared 
antibiotics (see section 2.2.1.4.), a 1 L sterile Schott bottle, a sterile filter in a sealed bag, and 
defrosted FBS were sterilised (see section 2.2.1.5.). The filter system was attached to the 
empty sterile Schott bottle and a vacuum was used to pull the liquid into the sterile bottle 
(Fig. 2.1). The bottle and cap were flame sterilised. The bottle of medium was removed from 
the laminar flow cabinet, labelled and stored at -4ᵒC. 
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2.2.1.7. Preparation of Phenol Red-Free MEM Containing 17.5% Stripped FBS 
Frozen stored stripped FBS (175 mL) was defrosted (15-20 min) in a 37  C water bath. One 
bottle of phenol red-free MEM powder was added to 825 mL of milliQ water in a 1 L Schott 
bottle whilst gently swirling to dissolve. The phenol red-free MEM powder bottle was rinsed 
with a small amount (approx. 5 mL) of milliQ water to remove any remaining powder; this 
was added to the Schott bottle. Sodium hydrogen carbonate (2.2 g) was added to the solution 
Figure 2.1: Vacuum filter containing 500 mL of MEM attached to an empty Schott bottle.  
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in the Schott bottle, this was swirled until dissolved. The solution was then adjusted to pH 
7.4. The phenol red-free MEM was sterilised by filtration (see section 2.2.1.6.) and stored at 
4  C 
2.2.1.8. Preparation of Eagle‟s Minimum Essential Medium (MEM) Containing 10% FBS 
The procedure was the same as that described in section 2.2.1.6. except 100 mL of 
inactivated FBS was used. 
2.2.1.9. Preparation of Phenol Red-Free MEM Containing 10% Stripped FBS 
The procedure was the same as that described in section 2.2.1.7. except 100 mL of stripped 
FBS and 900 mL of milliQ water were used. 
2.2.1.10. Trypsin Preparation 
NaCl (8.5 g) was dissolved in 1 L of MilliQ water, trypsin powder (25 g) was added to the 
0.85% (w/v) NaCl (aq) (1 L) and stirred (magnetic stirrer) at room temperature for 1 h. If any 
undissolved trypsin was present it was removed by filtration through Whatman No. 1 filter 
paper. The trypsin solution was then sterilised by filtration and dispensed into 10-20 mL 
aliquots and stored at -20  C. Ethylenediaminetetraacetic acid (EDTA) (3.72 g) was dissolved 
in to PBS (1 L) and sterilised by autoclaving. This PBS/EDTA (PE) solution was diluted 10-
fold with PBS, and 90 mL of the diluted PE was mixed with 10mL of trypsin solution to 
produce the final trypsin solution. This solution was stored at 4  C for a maximum of 3 weeks.  
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2.2.2. Cell Culture 
2.2.2.1. Cell Seeding 
One 100 μL cryovial containing approximately 5 x 105 rat testicular cancer Leydig cells, 
either R2C or LC-540, was removed from storage in liquid nitrogen and defrosted at room 
temperature (10-15 min). Culture medium (30 mL) was pipetted into a T-75 sterile culture 
flask using a sterile 10 mL glass pipette. The 100 μL cell suspension in the cryovial was 
added to the culture flask using a sterile micropipette with sterile tips. The flask was closed, 
removed from the sterile environment, and incubated at 37  C in a 5% CO2 atmosphere.  
2.2.2.2. Passaging (splitting) Cell Cultures 
Sterile Pasteur pipettes under vacuum suction were used to aspirate medium from the culture 
flasks, leaving the adherent cells behind. The flasks with adherent cells were rinsed with 2-4 
mL PBS. Either 3 mL TrypLE express (A protease mix preprepared by Life technologies that 
specifically cleaves the C-terminal side of Lysine and Arginine) or 2 mL prepared trypsin 
solution (see 2.2.1.10.) was added to the flasks. The flasks were returned to the incubator for 
5-15 mins until the cells were detached, this was observed using an inverted microscope. 
Sterile culture medium (10 mL) was added to inactivate the trypsin/TrypLE. The cell 
suspension was then transferred to 50 mL plastic centrifuge tubes and centrifuged at 4000 xg 
for 5 mins. The medium and trypsin/trypLE were aspirated (see above) from the centrifuge 
tubes and the pellets were resuspended in enough medium to seed the desired number of 
flasks (e.g. 3 flasks per tube corresponds to 30 mL medium per tube). Each flask had 20 mL 
of medium and 10 mL of cell suspension added using sterile pipettes. Flasks were incubated 
at 37  C in an atmosphere containing 5% CO2. 
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2.2.2.3. Cell Counting 
The cell suspension for counting (20 μL) was mixed with trypan blue (80 μL, 4 mg/mL 
dissolved in PBS), this solution was mixed and 10 μL was pipetted to the top grid of a 
cytometer (0.1 mm deep, area = 0.04 mm
2
) and a second 10 μL was pipetted to the bottom 
grid. A cover slip was placed over the cytometer and it was viewed at using an inverted 
microscope at 100x magnification. Each corner square on the cytometer‟s grids was counted 
and recorded (8 squares total) and the following formulae were used to determine the cell 
concentration:  
      (
 
 
)   
                  
 
2.2.2.4. Growth Curves 
Forty-five wells were seeded in three 15 well sets using three flasks. For each set the flask 
was treated with trypsin solution and centrifuged as stated previously (see section 2.2.2.2.). 
Each cell pellet was resuspended in 4 mL of medium (17.5% stripped FBS medium for R2C 
cells, 10% stripped FBS medium for LC-540 cells) and the cells were counted using a 
cytometer as stated previously (see section 2.2.2.3.). Based on the cell count, enough medium 
was added to give a cell concentration of 10
5
 cells/mL (5 x 10
4
 cells/well). Wells were seeded 
with 200 μL cell suspension. Medium (1.8 mL) was added to each well (repeated for the 
second and third set of 15 wells) resulting in a final starting cell concentration of 10
4
 
cells/mL. Every 24 hours, the culture medium from 3 wells was aspirated and 150 μL trypsin 
solution added; wells were incubated at 37  C at 5% CO2 for 5-10 mins, 350 μL of medium 
T = average number of cells in 1 x 10
-4 
mL; C = total cells counted; D = dilution factor; N = 
number of cytometer corner squares counted. 
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was added to inactivate the trypsin, and wells were counted (as stated in section 2.2.2.3) for 
ten-fifteen days (depending on speed of growth) and cell counts were plotted against time to 
produce a growth curve. 
2.2.3. Extraction of Steroids 
2.2.3.1. Cell Lysate Extraction 
Cells were lysed by centrifugation at 12,000 xg, the cell lysate was suspended in 500 μL of 
MilliQ water. Analytical grade diethylether (ether) (6 mL) was pipetted to a test tube with a 
glass stopper (to prevent evaporation). The cell lysate was added to the ether, the stopper was 
attached and the tube was inverted 10 times allowing the ether gas to escape by briefly 
loosening the stopper after each inversion. The mix was then given 2 min to separate into 
ether (top layer) and aqueous (bottom layer) phases. The ether layer was carefully removed 
with a Pasteur pipette and transferred into an open 15 mL test tube. The aqueous layer was 
then washed with another 6 mL ether and the inversion procedure was repeated two more 
times. The now separated ether layer was evaporated at 38  C under nitrogen gas flow until all 
ether was evaporated. Samples were then resuspended in 1.5 mL Analytical grade methanol 
(MeOH) and filtered using a non-sterile syringe filter (0.45μm) into a 1.5 mL glass HPLC 
vial prior to analysis. 
2.2.3.2. Cell Culture Medium Extraction 
The culture medium (30 mL) was defrosted at room temp (30 min). ether (60 mL) was 
measured into a separating funnel with glass stopper. The medium was added to the ether in 
the funnel and the stopper replaced. The funnel was then inverted 10 times allowing ether gas 
to escape by briefly loosening the stopper after each inversion. The mixture was allowed to 
stand (2 min) to separate the ether (top layer) and aqueous (bottom layer) phases. The 
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aqueous layer was run off into a 100mL beaker. The ether layer was then run off into a 250 
mL beaker. Another 60 mL of ether plus the aqueous layer (see 2.2.3.1.) was added to the 
separating funnel and the funnel inverted as described above. This was repeated twice. After 
the third separation the aqueous layer was discarded. Following each separation the ether 
phase was combined with the previous ether phases in the 250 mL beaker. The combined 
ether layers were evaporated in a 250 mL beaker standing in warm water until approximately 
15 mL of ether remained. The ether was then swirled around the sides of the beaker to 
remove any residue that had formed during evaporation, and transferred to a test tube (if any 
aqueous layer contamination was seen in the test tube the ether layer was carefully removed 
using a Pasteur pipette as described in 2.2.3.1. and moved to another test tube) and was 
evaporated at 38  C under a nitrogen gas flow.  The residue was dissolved in 1.5 mL MeOH 
and filtered into a HPLC vial prior to analysis. 
2.3. Analytical Techniques 
2.3.1. High Performance Liquid Chromatography (HPLC) 
Samples were analysed for steroids by reverse phase (C18) HPLC using a step gradient elution 
profile and UV absorbance detection via photodiode array (210, 245, 280 nm). Each sample 
had 50 μL injected per analysis and each injection batch included a MeOH blank and a no 
injection elution solvents only blank. 
2.3.1.1. HPLC System and Preparation 
A Dionex brand HPLC system was used for all analyses. The HPLC needle was washed 
using MeOH and primed 5 times with MeOH. The HPLC system was then purged with a 
solvent mixture comprising 10% Acetonitrile, 90% MilliQ water containing 0.05% v/v 
trifluoroacetic acid (3 mins at 3 mL/min).  
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2.3.1.2. HPLC Column 
A C18 Jupiter® reverse phase column was used to separate steroids 
2.3.1.3. Mobile phase 
Two elution buffers were used: Buffer A; MilliQ water containing 0.05% v/v trifluoroacetic 
acid, and buffer B; HPLC grade Acetonitrile. The following step gradients were used: 
10% standard gradient: 
90%A 10% B (0-2 min), 90%A 10%B-25%A 75%B (2-14 min), 25%A 75%B (14-24 min), 
25%A 75%B-0%A 100%B (26-30 min), 0%A 100%B (30-32 min), 0%A 100%B-90%A 
10%B (32-40 min), 90%A 10%B (40-42 min). 
55% Acetonitrile gradient: 
90%A 10% B (0-2 min), 90%A 10%B-50%A 50%B (2-18 min), 50%A 50%B (18-34 min), 
50%A 50%B-0%A 100%B (34-35 min), 0%A 100%B (35-41 min), 0%A 100%B-90%A 
10%B (41-46 min), 90%A 10%B (46-50 min). 
2.3.2. Calibration Graphs 
A 1 mg/mL standard of each analysed steroid was made up in MeOH and a 10-fold dilution 
series was prepared resulting in the following concentrations: 1 mg/mL, 0.1 mg/mL, 0.01 
mg/mL, 1 μg/mL, 0.1 μg/mL, and 0.01 μg/mL. These standards were then filtered and 
injected onto the column along with a MeOH blank and eluted with either the 10% standard 
gradient or the 55% Acetonitrile gradient (see 2.3.1.3.) and the steroids detected by UV 
absorbance at 210 nm, 245 nm, and 280 nm. The peak areas at their „ideal‟ wavelengths (i.e. 
the wavelength which gave the optimum peak area) was correlated against concentration to 
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give a calibration graph and the coefficient of determination (R
2
) was used to determine the 
accuracy of the standard curve (must be 0.99 or higher). The point at which a peak was no 
longer observable was deemed the limit of analytical detection. 
2.3.3. Limit of Determination 
A 1 mg/mL standard of each steroid was diluted appropriately and added to culture medium 
extract to give final concentrations of 5 ug/mL, 1 ug/mL, 500 ng/mL, 400 ng/mL, 300 ng/mL, 
200 ng/mL, or 100 ng/mL. These were injected onto the column along with a blank sample 
containing 10 μL MeOH. The lowest concentration at which the steroids could be detected 
was deemed the limit of determination (LoD). 
2.3.4. Spiked Samples 
To confirm the presence of a particular steroid, 100 μL of the sample being analysed was 
mixed with 100 μL of a standard concentration of steroid (e.g. 0.1 mg/mL cortisol producing 
a final concentration of 0.05 mg/mL cortisol in the sample). The peak area was measured and 
compared with the peak area of the steroid standard concentration. If the peak was larger and 
there were no peak shoulders the sample was identified as the standard steroid (i.e. the 
substances co-chromatographed). 
2.4. Dibutyl Phthalate Exposure 
Cell lines were passaged (see section 2.2.2.2.) into 12 T-75 flasks using phenol-red free 
medium and incubated until an approximate cell concentration of 5 x 10
5
 cells/mL was 
reached (this took 5 days). Their media were replaced with medium containing either 300 μL 
of ethanol (control flasks), or a specific concentration of DBP suspended in ethanol (total 
volume of 300 μL) (the following final DBP concentrations were covered in two separate 
experiments: 2.44 mg/mL, 0.287 mg/mL, 0.10 μg/mL, 5 μg/mL, 1 μg/mL, 0.1 μg/mL, and 
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0.086 μg/mL). Each concentration as well as the control was done in triplicate. Prior to 
exposure, cell cultures were viewed microscopically and observations of their morphology 
and general density were noted. Similar observations were made immediately after DBP 
exposures and every 24 hours until the cells were harvested. Cells were exposed to DBP for a 
total of 72 hours and then the medium was collected and frozen at -20  C until extracted as 
stated previously (see section 2.2.3.2.).  
The cells were then treated with either TrypLE or prepared trypsin (3 mL) for 5-15 min to 
detach the cells. Culture medium (10 mL) was added to the flasks to inactivate the 
trypsin/TrypLE. The medium and cells were transferred to 50 mL plastic centrifuge tubes and 
the cells counted (see section 2.2.2.3.) and total cell number determined based on the cell 
suspension‟s total volume. The cells were lysed by centrifugation at 12 000 xg; the medium 
was removed and replaced with 500 μL of MilliQ water. Steroids were extracted from the cell 
lysate using the ether extraction procedure described previously (see section 2.2.3.1.). The 
resulting cell extracts were analysed using HPLC procedure described previously (see section 
2.2.1.). Samples below the limit of detection were considered zero. 
2.5. Statistical Analysis of DBP Exposed Samples 
Data from each experiment was corrected to account for blanks by subtracting the average 
control peak area of each experiment from all other peak areas in that respective experiment. 
Experimental datasets were merged into one dataset and subjected to one way analysis of 
variance followed by Dunnett‟s multiple comparisons testing.  Natural logs of data were used 
for all statistical analyses to account for increased noise at high DBP doses due to DBP‟s 
cytotoxicity.  Differences were regarded as statistically significant at P < 0.05. 
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2.6. Exposure of LC-540 Cells to Cyclic AMP and Cyclic AMP Analogues 
Cell lines were passaged (see section 2.2.2.2.) into 3 T-75 flasks using phenol-red free 
medium and incubated (37  C 5% CO2) until an approximate cell concentration of 5 x 10
5
 
cells/mL was reached (this took approximately 5 days). Two flasks were exposed to either 
cyclic AMP or N
6
,2-O-Dibutyryladenosine3‟,5‟-cyclic monophosphate (DB-cAMP) 
(suspended in culture medium) at 0.5 and 1 mM respectively. The third flask was used as a 
control and was not exposed. Flasks were incubated for 48 hours and then harvested and the 
culture medium was extracted with ether as described previously (see sections 2.4. and 
2.2.3.2.). 
2.7. Phenol Red-Free FBS Stripped Culture Medium vs Regular Culture Medium 
To investigate the effect of phenol red and the hormone content of unstripped FBS R2C, 
triplicate cell cultures were grown in either regular medium or FBS stripped phenol red-free 
medium. Cells were counted and lysed and the resulting lysate had its steroids extracted and 
analysed by HPLC using the 10% standard gradient elution protocol (see sections 2.2.3.1., 
2.3.1.). 
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3.1. Steroid Analysis 
3.1.1. HPLC Calibration Graphs 
Calibration graphs were prepared by diluting stock solutions of progesterone, testosterone, 
and cortisol (see section 2.3.2) all had R > 0.99 (Fig. 3.1). These calibration graphs were used 
to calculate steroid concentrations in sample extracts. The analytical limits of detection were 
10 ng/mL (testosterone), 50 ng/mL (progesterone), and 50 ng/mL (cortisol). 
 
 
 
Figure 3.1: HPLC calibration graphs for testosterone, progesterone and cortisol. All steroid 
calibration graphs have R
2
 > 0.99. 
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3.1.2. Limit of Determination 
HPLC retention times (RT) for steroids using the 55% acetonitrile elution gradient (2.3.1.3.) 
were used to determine if a quantifiable change had occurred in spiked samples: Progesterone 
(RT = 22.8-22.9 min), testosterone (RT = 18.8 – 18.9 min) and cortisol (RT = 14.0 – 14.1 min) 
were analysed. All steroids had a LoD of 100 ng/mL (Table 3.1) which was the lowest spiked 
steroid concentration that gave a quantifiable change. This means that any steroid levels 
detected by HPLC below this limit are not valid and will not be considered significant. 
[Steroid] (ng/mL) Peak area (mAU/min) 
 
Cortisol Testosterone Progesterone 
0 5.43 0.2 0.03 
100 5.59 0.5 0.28 
200 5.66 0.62 * 
300 5.85 1.19 * 
400 5.99 1.14 * 
500 6.01 1.52 1.83 
1000 * * 4.34 
5000 * * 16.08 
 
3.2. Cell Culture Characterisation 
3.2.1. Growth Curves 
Table 3.1: LoD data for steroid-spiked culture media. All steroids were detectable at 100 ng/mL (5 
ng injected). Progesterone was the first steroid tested and was analysed much more broadly to 
determine if steroids could be detected at ng concentrations or only μg concentrations. 
Testosterone and cortisol were analysed at ng concentrations. All steroids were detectable at 100 
ng/mL. * = A concentration that was not tested (progesterone was the first steroid analysed so a 
broader range of concentrations were used than the later tested cortisol and testosterone). 
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Growth curves of both the R2C and LC-540 cell lines were collected using the same 
methodology (see section 2.2.2.4). Both R2C and LC-540 growth curves have clear lag, log, 
and death phases (Fig. 3.2). The LC-540 growth curve has a much longer lag time (10 days) 
than the R2C growth curve (5 days) (Fig. 3.2). The LC-540 growth curve has a peak cell 
number of approximately 1.5 x 10
5 
cells/well whilst the R2C growth curve has a peak cell 
number of approximately 1 x 10
6
.  
   
3.2.2. Cell Description 
R2C cells can be either oval or spherical when adhered to the culture vessel surface (Fig. 
3.3A). As R2C cell clusters become denser new cells grow on top of older cells until 
conglomerates are formed which are visible to the naked eye. LC-540 cells are quite 
different, they form a very thin widely spread monolayer when adhering to surfaces (Fig. 
3.3B). This monolayer is not visible to the naked eye. When LC-540 cells are treated with 
trypsin the monolayer peels off in a single sheet before the cells separate from one another, 
making the monolayer visible. When they are not adhered both LC-540 and R2C cells are 
spherical (Fig. 3.3C). 
 
Figure 3.2: Growth curves for LC-540 and R2C cell lines (mean ± SD). Lag, log and death phases in 
cell growth are labelled. LC-540 cells have a much longer lag time than R2C cells. 
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3.3. Phenol Red-Free FBS Stripped Culture Medium VS Regular Culture Medium 
Phenol red is a commonly used indicator of cell viability which reacts to CO2 production 
indicating when cell overpopulation or contamination has occurred. However, phenol red is a 
known xenoestrogen and thus could cause changes in steroid biosynthesis. FBS is known to 
contain trace levels of steroids which can be removed using serum stripping (see section 
2.2.1.3.). To determine whether the removal of phenol red and these trace steroids caused a 
significant change in steroidogenesis the steroids in R2C cells grown in both standard culture 
media and phenol red-free FBS stripped culture media were analysed for significant 
B A 
C 
Figure 3.3: Images of cells in culture in T-75 culture flasks at 100x magnification. A: R2C cells at 
confluence adhered to a culture flask. Both spherical and oval cells can be seen adhered to the 
flask. B: LC-540 cells at confluence adhered to a culture flask. Cells are more spread out when 
adhered to the flask when compared with the R2C cells. C: R2C cells following the trypsin 
detachment process. Cells are spherical in shape. LC-540 cells also look like this when exposed to 
trypsin. 
Spherical cell 
Oval cell 
Spherical cell 
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differences which were found. Progesterone levels were higher and cholesterol levels lower 
in extracts from cells grown in standard culture media compared with those grown in phenol 
red-free FBS stripped culture media (Fig. 3.4, 3.5). This suggests that either phenol red or 
FBS steroids are inducing the stimulation of steroidogenesis because progesterone is the R2C 
cell line‟s main steroid product and cholesterol is a universal steroidogenesis precursor. 
Because of this, all future samples will be grown in FBS stripped phenol red-free media to 
remove this background stimulation. 
Figure 3.4: HPLC trace of R2C cell lysate extract (cells were grown in standard 17.5% MEM) 
measuring the absorbance at 245 nm. Peaks at 16.313 and 20.773 mins correlate to progesterone 
and cholesterol respectively. 
Progesterone Cholesterol 
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3.4. Determining Analytical Background Noise 
3.4.1. Stripped Media Analyses 
Stripped culture medium was analysed using HPLC chromatography standard 10% elution 
gradient (see section 2.3.1.) and the HPLC trace was analysed for any peaks correlating with 
known steroid retention times (Fig. 3.6). No peaks correlating with testosterone, 
progesterone, and cholesterol were seen but a peak correlating with cortisol was seen. 
However, the UV spectrum of the peak does not match with cortisol‟s UV spectra (Fig. 3.7). 
Figure 3.5: HPLC trace of R2C cell lysate extract (cells were grown in Serum stripped 17.5% 
phenol red-free MEM) measuring the absorbance at 245 nm. Peaks at 16.313 and 20.773 mins 
correlate to progesterone and cholesterol respectively. 
Progesterone 
Cholesterol 
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Figure 3.6: HPLC UV absorbance trace of stripped media measured at 245 nm. A: 17.5% 
stripped FBS phenol red-free MEM (used with R2C cells). B: 10% stripped FBS phenol red-free 
MEM (used with LC-540 cells). Peaks correlating with cortisol can be seen in both samples of 
medium. 
A 
B 
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3.4.2. Ether Extraction Analysis 
Media was extracted using ether (see section 2.2.3.2.) and 180 mLs of pure ether was 
evaporated in triplicate as stated in section 2.2.3.2., analysed using HPLC (see section 2.3.1.) 
and compared (Fig. 3.8). The peaks observed are identical between the two samples showing 
that all background noise in analysis is a result of compounds found in the ether residue. 
Figure 3.7: UV spectra of cortisol compared with the peak found in medium. (A) The UV spectra 
of the peak in stripped FBS media with the same retention time as cortisol, peaking in absorbance 
at approximately 200 nm. (B)The UV spectra of a standard 1 mg/mL cortisol sample. The primary 
absorbance peak for the cortisol standard is at approximately 245 nm. 
A 
B 
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Cortisol background noise levels are constant between samples as the three ether samples 
have identical peak areas for the peak associated with cortisol (Table 3.2). On the other hand, 
there is variation in background noise between bottles of ether. However, because a 
maximum of one ether bottle was used in each experiment, any changes in steroid peaks 
within that experiment are significant. To account for this non-cortisol background noise, the 
average cortisol peak area of the control samples of each exposure experiment were 
subtracted from all other cortisol peak area values (control samples had the lowest cortisol 
peak area in all exposure experiments). 
 
 
Figure 3.8: HPLC trace measuring of both extracted media and „ether‟ residues absorbance at 
245 nm. Both traces are identical.  A: UV trace of fresh media extract. B: UV trace of „ether‟. 
residues. 
A 
B 
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Sample Peak area at RT 13.8min (mAU/min) 
Ether extract 1 6.08 
Ether extract 2 6.08 
Ether extract 3 6.07 
 
3.5. HPLC Method Development 
Cell lysate was harvested and extracted from unexposed cells to confirm the presence of 
steroids (see section 2.2.3.1.) using the standard 10% HPLC elution gradient (see section 
2.3.1.3.). Peaks co-chromatographing with progesterone (RT 16.3) and cholesterol (RT 20.8) 
were observed in samples (Fig. 3.9) (these peaks had their identities confirmed by comparing 
their UV spectra with known steroid spectra). 
However, due to peak overlap, particularly with progesterone (Fig. 3.9), the elution protocol 
was altered to smooth out the gradient. This resulted in the 55% acetonitrile protocol with 
much more spread out peaks, thus increasing the accuracy of peak identification and 
quantification (Fig. 3.10). 
 
Table 3.2: Peak areas of „ether‟ extracts at cortisol‟s retention time (RT: 13.8). All samples had 
identical peak areas. 
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3.6. Cell Counting Method Development 
The original TrypLE express mix proved ineffective at remove all cells attached to the flask 
and did not separate individual cells well resulting in cell clumping which causes inaccuracy 
in cell counts (Fig. 3.11A). To remedy this, trypsin was dissolved in solution (see section 
2.2.1.10.). This trypsin solution resulted in the removal of all cells from the plastic surface 
Figure 3.9: HPLC trace measuring UV absorbance at 245 nm of R2C cell lysate extract (cells were 
grown in standard 17.5% MEM). Peaks at 16.313 and 20.783 mins correlate to progesterone and 
cholesterol respectively. A small interfering peak can be seen next to the progesterone peak. 
Figure 3.10: HPLC trace measuring UV absorbance at 245 nm of R2C cell lysate extract (cells were 
grown in standard 17.5% MEM) using the 55% acetonitrile elution protocol. Peaks at 22.867 and 
30.680 mins correlate to progesterone and cholesterol respectively. A small peak can be seen next to 
the progesterone peak. 
Progesterone 
Cholesterol 
Progesterone 
Cholesterol 
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and produced much better separation between cells resulting in a much more accurate count 
(Fig. 3.11B). Dissolved trypsin powder was then used for all future experiments. 
 
3.7. Cell Steroid Production 
3.7.1. R2C Extractions 
Unexposed R2C cells were grown for 5 days, had their media replaced, and were harvested 
three days later (see section 2.4.). Both the cell lysate and culture medium were extracted (see 
sections 2.2.3.1., 2.2.3.2.), analysed for steroid content (see section 2.3.1.) and compared 
(Fig. 3.12). 
In both the cell lysate and medium extracts progesterone peaks can be seen (Fig. 3.12). The 
much larger peaks in the culture medium will be easier to identify and any changes will be a 
greater distance from the LoD making the culture medium extract a much more useful tool in 
analysing steroid content. A cortisol peak is also observed but this could be due to the 
background noise produced by the ether (see section 3.4.2.) so it cannot be conclusively 
Figure 3.11: Cells detached from the surface of their culture flask using either: A: trypLE express, 
or B: trypsin solution. Cells are much more clustered when using trypLE express.  
A B 
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identified as cortisol at this time. However, because the background noise is constant (see 
section 3.4.2) any increases in this peak would be indicative of cortisol production. 
 
 
Figure 3.12: HPLC trace showing UV absorbance at 245 nm from: A: R2C cell lysate extract, or B: 
R2C culture medium extract. Peaks with matching retention times to cortisol and progesterone are in 
both samples. Progesterone was confirmed present by comparing the UV spectra of the peak at 22.8 
with the UV spectra of a 1 mg/mL standard (both peak in absorbance at 245 nm). Steroid peaks are 
much larger in extracted culture medium making the analysis of cells culture medium a much more 
effective way to quantify relative steroid production. 
A 
B 
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3.7.2. LC-540 Extractions 
Unexposed LC-540 cells were grown for 5 days, had their media replaced, and were 
harvested three days later (see section 2.4.). Both the cell lysate and culture medium were 
extracted (see sections 2.2.3.1., 2.2.3.2.), analysed for steroid content (see section 2.3.1.) and 
compared (Fig. 3.12). 
In the culture medium extract both testosterone and progesterone peaks can be seen as well as 
a potential cortisol peak (Fig. 3.13). However, as with the R2C extracts the potential cortisol 
peak could be due to background noise produced by the use of ether so this cannot be 
conclusively identified as a cortisol peak. The LC-540 cells produce testosterone unlike R2C 
cells but they do not produce nearly as much progesterone as R2C cells. No significant 
steroid peaks can be identified in the cell lysate extract but testosterone and progesterone can 
be positively identified in culture medium extract (Fig 3.13). Because of this, culture medium 
extract will be used to identify and quantify steroids produced by the cells in future 
experiments. 
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3.8. Determining DBP Exposure levels 
R2C cells were exposed to doses of 2.44, 0.287 mg/mL, and 0.086 μg/mL DBP (see section 
2.4.) (high concentrations are estimations of DBP present in the blood of New Zealand 
soldiers based on Carran and Shaw‟s exposure study (assuming 70kg and 3.3L serum 
Figure 3.13: HPLC trace measuring UV absorbance at 245 nm from: A: LC-540 cell lysate 
extract, or B: LC-540 culture medium extract. Peaks with matching retention times to cortisol and 
testosterone are seen in the extracted culture medium. Testosterone and progesterone were 
confirmed present by comparing the UV spectra of the peaks at 18.9 and 22.8 with the UV spectra 
of 1 mg/mL standards (all of which peak in absorbance at 245 nm). Like the R2C extract steroid 
peaks were much larger in the medium extract making media analysis a much more effective way 
to quantify relative steroid concentrations. 
B 
A 
Progesterone 
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volume) (Carran & Shaw 2012), low dose based on average adult dietary exposure in 
Denmark (assuming 70kg and 3.3L serum volume) (EFSA 2005)). 
R2C cells exposed to levels of 0.287 and 2.44 mg/mL DBP have a large decrease in cell 
numbers. These high doses resulted in the formation of insoluble globules (Fig. 3.14), cortisol 
culture media levels that were too variable to be considered significantly different from the 
control (Fig. 3.15), and progesterone culture media levels that were significantly decreased 
(Fig. 3.16). However, this progesterone decrease could be due to the limitations of the cell 
count at low cell concentrations (1 x 10
4 
is the lowest possible cell count, but cells may be at 
an even lower concentration). Samples exposed to 0.086 μg/mL doses of DBP showed no 
observable effect on cell number or cell morphology (Table 3.3, Fig. 3.14) as well as no 
significant change in cortisol or progesterone culture media levels (Figs. 3.15, 3.16). 
Testosterone was not detected (below the LoD) in any of the culture media analysed.  In all 
future experiments samples were exposed to DBP levels below the saturation concentration 
of DBP in water (13 μg/mL) to avoid the formation of insoluble globules and above the 
lowest exposure tested (0.086 μg/mL) as it had no observable effect on cortisol or 
progesterone production.  
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DBP Exposure Rep 1 (cell/mL) Rep 2 (cell/mL) Rep 3 (cell/mL) 
0 mg/mL 2 x 10
5 
1.9 x 10
5 
2 x 10
5 
8.6 x 10
-5
 mg/mL 2.6 x 10
5 
1.4 x 10
5
 2.4 x 10
5
 
0.297 mg/mL 9.4 x 10
4
 3.7 x 10
4
 5 x 10
4
 
2.44 mg/mL 1.8 x 10
4
 1 x 10
4
 1 x 10
4
 
 
Table 3.3: Cell counts of all samples 72 hours after exposure to DBP. Cell count is lower in high 
exposure samples. 
Figure 3.14: Photographs of R2C cells exposed to various DBP concentrations after 24 hours. A: 
Control cells B: Cells exposed to 0.086 μg/mL DBP. These are very similar to control samples. C: 
Cells exposed to 0.3 mg/mL DBP. Small insoluble globules can be seen adhering to the surface of 
the flask. D: Cells exposed to 2.4 mg/mL DBP. Insoluble globules have almost completely covered 
the surface of the flask resulting in the majority of the R2C cells removal. 
A B 
C D 
Insoluble globule 
R2C cells 
Insoluble globule 
R2C cells 
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3.9. Exposure of R2C Cells to DBP 
Following the previous exposure of R2C cells to a broad range of DBP doses (see section 
3.8) a second exposure experiment was run using the same methodology (see section 2.4) 
exposing the R2C cells to a less broad range DBP doses (0.1, 1, 5, and 10 μg/mL). Cortisol 
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Figure 3.15: Cortisol levels in culture media from R2C cells exposed to DBP for 72 h showing 
DBP-induced biosynthesis of cortisol (error bars = standard deviation).   
Figure 3.16: Progesterone levels in culture media from R2C cells exposed to DBP for 72 h 
showing a decrease in progesterone at cytotoxic concentrations(error bars = standard deviation) 
(*= P<0.05 with respect to control).   
* 
* 
Chapter 3 – Results 
72 
 
culture media levels in all DBP exposed R2C cells were significantly (P < 0.05) greater than 
control culture media levels (Fig. 3.17).  Progesterone culture media levels were unaffected 
by DBP exposure (Fig. 3.18).  Testosterone was not detected (below the LoD) in any of the 
culture media analysed.   
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Figure 3.17: Cortisol levels in culture media from R2C cells exposed to DBP for 72 h showing 
DBP-induced biosynthesis of cortisol (error bars = standard deviation) (*= P<0.05 with respect 
to control).   
Figure 3.18: Progesterone concentrations in culture media from DBP-exposed R2C cells showing 
that DBP exposure did not affect the biosynthesis of progesterone (error bars = standard deviation). 
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3.10. Effects of Cyclic AMP in LC-540 Steroid Biosynthesis 
Because the R2C cell line does not produce testosterone it is not the ideal cell line for 
analysis. However, the LC-540 cell line does produce detectable levels of testosterone. To 
further investigate this cell lines use as an accurate Leydig cell model cAMP‟s ability to 
regulate testosterone biosynthesis was investigated in a brief one-off experiment. In normal 
Leydig cells increased levels of internal cAMP upregulates steroidogenic enzymes resulting 
in increased testosterone biosynthesis. The cAMP analogue DB-cAMP was also investigated 
because it is known to permeate cell membranes efficiently. Testosterone peak areas do not 
significantly change in LC-540 cells exposed to cyclic AMP (Table 3.4). LC-540 cells 
exposed to 1mM DB-cAMP seem to more than double in their production of testosterone 
(Table 3.5). However, as this is a one off experiment this cannot be confirmed.  
Sample Peak area at RT 18.8min (mAU/min) 
LC-540 0mM cyclic AMP 2.0 
LC-540 0.5mM cyclic AMP 2.3 
LC-540 1mM cyclic AMP 2.1 
 
 
 
Table 3.4: Peak areas of cyclic AMP exposed LC-540 culture medium extracts at testosterone‟s 
retention time (RT: 18.8). 
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Sample Peak area at RT 18.8min (mAU/min) 
LC-540 0mM DB-cAMP 1.8 
LC-540 0.5mM DB-cAMP 1.7 
LC-540 1mM DB-cAMP 4.4 
 
 
 
Table 3.5: Peak areas of DB-cAMP exposed LC-540 culture medium extracts at testosterone‟s 
retention time (RT: 18.8). 
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4.1. A Brief Summary of Endocrine Disruption and Reproductive Development 
4.1.1. Testosterone‟s Role in Male Development 
Both testosterone and DHT are the key androgens involved in the expression of the male 
phenotype. During fetal development these hormones promote the formation of the Wolffian 
duct, male external genitalia and stimulate testes descent (Jost 1953; Yeh et al. 2002; Brown 
1995; Russell & Wilson 1994; Hutson et al. 1997). DHT is synthesised from testosterone by 
5α-reductase in specific tissues (Deslypere & Young 1992; Russell & Wilson 1994; 
Mahendroo & Russell 1999). The majority of the testosterone metabolised by 5α-reductase 
(as well as most of the testosterone used to express male characteristics throughout the body) 
is synthesised by testicular Leydig cells. These Leydig cells are the primary source of 
testosterone in the male (Christensen & Mason 1965; Wattenberg 1958) though testosterone 
is also secreted in small amounts by the adrenal gland (Tanabe et al. 1979). Therefore, any 
change in Leydig cell testosterone secretion (particularly during early development) will 
affect an individual‟s male characteristics. The degree of this effect will be directly related to 
the change in testosterone exposure. For example, detrimental effects can be seen in those 
with androgen insensitivity syndrome; this can be caused by a number of deleterious 
mutations on the AR gene (these can be complete removal of the AR gene via an early stop 
codon or point mutations interfering with the androgen binding domain or the DNA binding 
domain) (Brown 1995). Those who suffer from this condition can have a variety of 
developmental disorders ranging from infertility to muscular atrophy during adulthood in 
mild cases to expressing the female phenotype in severe cases (Brown 1995). 
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4.1.2. Endocrine-Disrupting Chemicals 
EDCs interfere with the endocrine system which includes the male hormone testosterone and 
the female hormone 17β-estradiol.  These compounds are very common and can disrupt 
steroid hormone activity in a variety of ways. Some mimic their associated hormones. For 
example, 17β-estradiol mimics bind to the ERs increasing estrogenic activity. Activated ERs 
stimulate the expression of the female phenotype stimulating the division of cells in female 
tissue and supress the androgen production of Leydig cells (Akingbemi 2003; Kalla et al. 
1980). Other EDCs can cause the adverse effects by targeting hormone activity. For example, 
antiandrogens can target the AR and occupy the binding site so that testosterone and DHT 
cannot bind reducing androgen activity and male phenotype expression (Kelce & Wilson 
1997). Another method of endocrine disruption is via hormone synthesis. Compounds can up- 
or down-regulate key enzymes involved in steroid synthesis. Some can stimulate the 
synthesis of estrogens by up-regulating aromatase and other key steroidogenic enzymes 
(Younglai et al. 2004; Whitehead & Rice 2006). EDCs  can cause a range of developmental 
disorders from precocious puberty and an increased incidence of breast cancer in females to 
demasculinisation and increased incidences of reproductive defects such as hypospadias and 
cryptorchidism in males (this effect has been observed only in animal studies) (Gray et al. 
2001; Bhatt 2000). This is because the ratio of androgens to estrogens is essential in 
determining whether male or female traits are expressed in early development. This is due to 
the fact that the active AR can inhibit ER action and vice versa (Akingbemi 2003; Peters et 
al. 2009). Therefore, any decrease in testosterone activity is equivalent to an increase in 
estrogenic activity because less ER is inhibited. Because of this androgens suppress the 
growth of healthy and cancerous breast cells which grow in response to estrogen stimulation. 
Removal of this suppression could lead to an increased chance of developing breast cancer 
because any cancerous mutation in a breast cell is more likely to divide under estrogen 
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stimulation leading to tumour formation (Kelce & Wilson 1997). On top of this some EDCs 
have a multigenerational effects (Dolinoy 2008) meaning these effects could take place 
during the early development of successive generations. Reproductive EDCs can cause a 
variety of detrimental effects via a variety of mechanisms, on top of this many of them are 
common environmental contaminants and some are still in use (for specific examples see 
section 1.2.2.). Identifying these EDCs and characterising their mechanisms of toxicity is the 
first step in ensuring that appropriate regulatory standards are in place. Based on what effects 
EDCs have on hormone synthesis, enzyme expression, and what these effects will have in the 
long-term will all contribute towards regulatory decisions. Informed regulatory decisions will 
result in the appropriate exposure limitations being implemented decreasing overall exposure 
to levels with no adverse effects. 
4.1.3. The Effects of Dibutyl Phthalate and Other Phthalate Esters 
DBP (along with other phthalates) is used as a plasticiser, stabiliser and pesticide in a variety 
of products, including cosmetics, inks, food packaging, adhesives and acaricides making it a 
ubiquitous environmental and food contaminant (Foster et al. 2000; Xiao-feng et al. 2009; 
Janjua et al. 2007; Carran & Shaw 2012). DBP is a known EDC and causes reproductive 
defects (e.g. hypospadias) in multiple animals across a broad evolutionary spectrum, 
including frogs (Rana rugosa) and rats (Mankidy et al. 2013; Pant et al. 2011; Ohtani et al. 
2000; Wolf et al. 1999; Parks et al. 2000). Exposure of pregnant rats to phthalates 
(particularly DBP) resulted in their male offspring having reduced testosterone levels 
compared to controls (Howdeshell et al. 2008). How phthalates cause this decrease in 
testosterone has been the subject of discussion for many years. Some propose that direct 
inhibition of key steroidogenic enzymes is responsible (Yuan et al. 2012); whilst others 
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suggest that an epigenetic mechanism involving gene expression resulting in altered enzyme 
activity is responsible (Martinez-Arguelles et al. 2013). 
Human exposure to phthalates is widespread due to the extensive use of these compounds. 
However, the implications of phthalate exposure on human health are difficult to determine 
because humans are exposed to multiple EDCs with common endpoints (e.g. male 
reproductive malformations). Recently Carran and Shaw (2012) showed a statistically 
significant increase in the incidence of hypospadias and cryptorchidism in the children of 
soldiers exposed to high levels of DBP (used as an acaricide to kill Trombiculid mites that 
carry bush typhus) (Carran & Shaw 2012; Elwood & Borman 2012). This suggests that DBP 
could have a multigenerational effect. However, most animal studies have only been exposed 
whilst pregnant resulting in the embryo receiving direct exposure to DBP rather than looking 
at long term multigenerational effects. These effects could be due to either mutagenic 
changes or epigenetic changes. DBP has been shown to be mildly mutagenic (Seed 1982; 
Kleinsasser et al. 2001). However, this is most likely general mutagenicity and would not 
necessarily result in multigenerational endocrine disruption. Another possibility is that DBP‟s 
effects are multigenerational via an epigenetic gene regulatory mechanism. This type of 
mechanism has been seen in other EDCs. BPA causes multigenerational epigenetic effects 
via alterations of DNA methylation patterns resulting in changed gene expression (Dolinoy 
2008). It has been shown that BPA increases the expression of genes coding for DNA 
methyltransferase enzymes (DNMT1 and DNMT3A specifically) these enzymes methylate 
specific DNA residues. This paralleled an increase in ERα expression associated with 
methylation changes in the ERα gene (Kundakovic et al. 2013). Exposing a generation of rats 
to a combination of DBP, DEHP and BPA caused an increased incidence of testis disease 
three generations later (Manikkam et al. 2013). This could be due to BPA but the fact that 
there is an increased incidence of genital diseases in the soldier‟s children in Carran and 
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Shaw‟s study (Carran & Shaw 2012) suggests that DBP may have contributed to this effect; 
possibly via alterations of DNA methylation in genes responsible for the production of 
testosterone biosynthetic enzymes. This suggests that there is a significant multigenerational 
effect following DBP exposure. However, as only one subsequent generation was 
investigated in Carran and Shaw‟s study (Carran & Shaw 2012) whether this is a temporary 
change that will disappear after a few generations (i.e. it is an epigenetic effect) or whether 
this increased incidence persists (i.e. it is a mutagenic effect) is unknown.  
4.2. Data from the Present Study 
4.2.1. Characterisation of Cell Lines  
Two Leydig cancer cell lines were the focus of this study. The first was the R2C cell line. 
R2C cells are spherical in shape and adhere to flasks when grown in culture. Once adhered, 
the spherical cells spread out becoming more oval shaped (Fig. 3.3A). When R2C cells are 
grown small conglomerates of cells visible to the naked eye, will begin to form by day 4, 
these cell conglomerates will continue to grow rapidly until they come into contact with each 
other and reach confluence and reach a maximum cell population of approximately 2 x 10
6
 
cells/mL (approx. day 8). By this point cells will cease growing and begin to die due to 
overpopulation (Fig. 3.2). When R2C cells are exposed to concentrated levels of DBP the 
morphology and growth of R2C cells is negatively impacted (see section 4.2.2.). The R2C 
cell line was chosen for two reasons. Firstly, it had been shown that they constitutively 
expresses all of their steroidogenic enzymes making them able to produce steroids without 
having to be chronically stimulated by LH or a cAMP analogue (Freeman 1987). This 
allowed the analysis of DBP exposure‟s effects on steroid biosynthesis to be much easier 
because chronic stimulation of the cells with LH or DB-cAMP did not have to be accounted 
for. However, the downside to this constitutive expression is that any changes in testosterone 
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synthesis due to interference with LH and cAMP stimulation cannot be observed in the R2C 
cell line. Secondly, a recent BSc Honours report suggested that R2C cells produced 
testosterone (Carran 2010). This made R2C cells a good model for studying the effects of 
DBP exposure on testosterone synthesis. However, in the present study it was shown, whilst 
the R2C cell line synthesises large quantities of progesterone, testosterone was undetectable 
(Fig. 4.12). It has recently been confirmed that testosterone is being made by the R2C cells, 
but it is not made at a level that can be detected using HPLC analysis (Balbuena et al. 2013). 
This might, in turn, be explained by a decrease in the expression of CYP17 as this enzyme is 
necessary for testosterone synthesis. However, complete loss of this enzyme‟s functionality is 
unlikely as R2C cells are capable of synthesising cortisol which requires CYP17‟s 17α-
hydroxylyase activity to produce a key intermediate, 17α-hydroxyprogesterone (Fig. 4.1). 
Alternatively, 17β-HSD could be inactive or its expression could be reduced leaving the R2C 
cells with the ability to make detectable levels of cortisol but not detectable levels of 
testosterone. Because cortisol can be synthesised by R2C cells at observable levels this is 
more likely. This meant the exposure studies carried out using the R2C cell line could not 
look at testosterone biosynthesis, but rather only changes in progesterone and cortisol 
biosynthesis (see section 3.9). This prompted an investigation into a new cell line that could 
produce quantifiable amounts of testosterone, namely the LC-540 Leydig cell line. 
Like the R2Cs the LC-540 Leydig cell line is adherent. However, the LC-540 line has a much 
longer growth lag period of about 10 days before rapid growth begins to occur (compared to 
5 days for the R2Cs) (Fig. 3.2). LC-540 cells are spherical when suspended in media but once 
adhered they become very spread-out and do not form visible cell conglomerates. Instead, by 
day 11 LC-540 cells will form a monolayer which can only be identified under a 100x 
magnification and even then the individual cells are so spread out it is sometimes difficult to 
see their membranes (Figs. 3.2, 3.3B). By day 13 growth ceased and dead cells were seen 
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suspended in media (Fig 3.2.). By day 17 the monolayer began to peel off the surface of the 
flask (Fig. 3.2). It is interesting to see that even though both of these cell lines were isolated 
from Leydig cell tumours they differ greatly in both morphology and growth rate. They also 
differ in their steroid biochemistry. This was shown when LC-540 media extracts contained 
quantifiable levels of testosterone and progesterone (Fig. 3.13B). This is supported by the 
literature, LC-540 cells are known to synthesise and secrete testosterone and 17β-estradiol 
(Steinberger et al. 1970) (Fig. 4.1). This means that LC-540 cells express all of the enzymes 
necessary to synthesise testosterone and have not lost their ability to express these enzymes in 
their active forms. The expression levels of genes coding for essential steroidogenic enzymes 
in LC-540 cells seem to be regulated by internal cAMP concentration. This was hinted at in 
the present study when exposure of LC-540 cells to 1mM of the cAMP analogue DB-cAMP 
seemed to stimulated steroidogenesis (see section 3.10.). Unbutylated cAMP however, did 
not stimulate steroid synthesis (see section 3.10.). This is most likely due to cAMP being 
unable to pass through the cell membrane due to cAMPs highly hydrophilic structure. This 
suggests that LC-540 cells may have retained the proteins responsible for cAMP induced 
expression of the genes coding for steroidogenic enzymes (Gyles et al. 2001). However, it is 
unknown whether LC-540 cells respond to pituitary peptide hormones (such as LH) like 
isolated Leydig cells do (Ge & Hardy 1998). The regulatory action of cAMP on the LC-540 
cell line has not been investigated previously. However, even without stimulation, LC-540 
cells synthesise quantifiable amounts of testosterone. The combination of the LC-540 cell‟s 
ability to synthesise testosterone along with the potential retention of the internal cAMP 
stimulatory response makes this cell line a much better model for the assessment of a 
compounds effects on steroidogenesis than the R2C cell line with their undetectable 
testosterone biosynthesis and lack of a cAMP steroidogenesis regulatory mechanism. 
Therefore LC-540 cells would be ideal as a model to investigate the effects of DBP on 
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testosterone biosynthesis. However, due to time constraints and difficulty setting up LC-540 
cell cultures only R2C cells could be exposed to DBP and have their steroid secretions 
analysed. 
 
 
 
Figure 4.1: Steroidogenesis pathway showing which constituents of the pathway each cell line is 
capable of synthesising. The R2C cells are capable of synthesising Cortisol when stimulated and 
LC-540 cells are known to synthesise testosterone and 17β-estradiol (Steinberger et al. 1970). ►= 
LC-540 steroidogenesis activity, ► = R2C steroidogenesis activity. Small blue arrows indicate 
documented testosterone synthesis that was undetected in the current study (Balbuena et al. 2013). 
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4.2.2. Determination of Relevant DBP Exposure Concentrations 
Exposure of R2C cells to 0.297 and 2.44 mg/mL DBP resulted in almost 100% cell death as 
cell concentrations in these samples were significantly lower than control levels, whilst a 
DBP exposure level of 8.6 x 10
-5
 mg/mL caused no observable cell death (Table 3). The cell 
death seen at very high DBP exposure levels was likely caused by the formation of insoluble 
DBP globules in the culture medium due to DBP oversaturation; this was seen in high DBP 
exposure samples (Fig. 3.14B, C). Because DBP has an extremely high octanol/water 
partition coefficient (LgPow) (between 4.31 and 4.79) (WHO 1997) it is possible that cells 
that came into contact with the globules rapidly absorbed large quantities of DBP into their 
membranes. This in turn could lead to membrane property changes akin to those seen when 
cholesterol levels in membranes are high. High membrane cholesterol levels result in changes 
in phospholipid R-group packing and this alters membrane fluidity. DBP might act in a 
similar way because it too is likely to dissolve in the phospholipid R-groups disrupting 
membrane packing in a manner similar to cholesterol (Gleason et al. 1991). This will alter the 
membranes fluidity disrupting normal membrane function which in turn will lead to the loss 
of surface protein functionality (Fig. 4.2). This could explain the massive loss in cell number 
at high exposure levels. 
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These effects are less likely to been seen in vivo. This is because DBP is rapidly metabolised 
to MBP by multiple esterases. These esterases are most active in the liver (Hanioka et al. 
Figure 4.2: Potential mechanism of toxicity of DBP at levels insoluble in culture medium. 
Large quantities of DBP might enter the cell membrane when a cell comes in contact with 
an insoluble globule. This could lead to alterations in membrane fluidity due to changes in 
phospholipid packing disrupting the membrane and its protein‟s function. A: Cell 
membrane structure. B: A disrupted cell membrane exposed to a concentrated globule of 
DBP. 
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2012). However, many non-specific esterases are produced throughout the body (including 
Leydig cells). These non-specific esterases can also catalyse DBP hydrolysis (Molenaar et al. 
1986) both in vivo and in vitro. The in vivo metabolism of DBP is, in fact, so rapid that no 
DBP was detected in the plasma and urine of rats dosed with 100 mg/kg body weight [
14
C]-
DBP. MBP and MBP glucuronide were instead the two major components found in both 
urine and serum within two hours of administration (Fennell et al. 2004). However, there will 
be no first pass effect through the gut when DBP is applied topically as in Carran and Shaw‟s 
DBP exposed soldiers (Carran & Shaw 2012) as DBP will be directly absorbed through the 
skin into the blood. But, due to the high concentration of non-specific esterases in the skin 
(Montagna 1955) DBP is likely going to be mostly hydrolysed to MBP before it reaches the 
blood. Because MBP has lost one of its butyl groups and has gained a carboxylic acid 
hydroxyl group (which can be deprotonated and delocalise its negative charge with the other 
carboxylic acid oxygen) this will make it much more water soluble than DBP meaning less 
insoluble globules will form in the blood. It has been suggested that MBP is responsible for 
DBP‟s endocrine-disrupting effects (Clewell et al. 2010). The majority of a DBP dose was 
excreted within 24 hours of administration (Fennell et al. 2004) this removal of DBP via 
excretion is obviously impossible during an in vitro exposure. Considering most in vivo 
studies of phthalates are either via oral (Howdeshell et al. 2008; Howdeshell et al. 2007; 
Parks et al. 2000) or skin exposure (Carran & Shaw 2012; Carran & Shaw 2010) the skin and 
liver will metabolise a significant percentage of the DBP prior to it reaching the testis and 
Leydig cells. This means physical toxicity such as the effects seen at 2.44 and 0.297 mg/mL 
doses are unlikely to occur in vivo. Therefore these concentrations are inappropriate for 
further analysis of DBP‟s effects on steroid synthesis. 
There were no significant changes in cortisol production at DBP exposure levels 8.6 x 10
-5
 
and 0.294 mg/mL (Fig. 3.15). Cortisol production was below the LoD at DBP exposure level 
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2.44 mg/mL and sample noise was much greater than the control at DBP exposure level 
0.294 mg/mL (Fig. 3.15). Progesterone decreased significantly (P < 0.05 when compared to 
control) at both 0.294 and 2.44 mg/mL DBP doses (Fig. 3.16). However, these apparent 
decreases in steroid production are likely due to inaccuracies in cell count. Particularly the 
samples exposed to 2.44 mg/mL DBP have cell concentrations of approximately 1 x 10
4
 
cells/mL this is well out of the accurate range (1 x 10
4 
cells/mL corresponds to one cell on the 
haemocytometer). Due to this inaccuracy, it is much more likely that the actual cell 
concentration is less than that counted. Because of this, when the steroid concentrations were 
normalised, the overestimated cell concentration resulted in an apparent overall decrease in 
steroids concentration produced on a per cell basis. Alternatively, cells could be down 
regulating the steroid pathway to conserve metabolic energy for vital pathways in response to 
a general toxic insult. Regardless of these inaccuracies, these concentrations are inappropriate 
for looking at the biochemical effects of DBP on Leydig cells. This was either due to the 
absence of an observable effect (as seen in the samples exposed to 8.6 x 10
-5
 mg/mL DBP) or 
due to the toxic insult losing its specificity and causing a physical toxic effect (seen in the 
samples exposed to 0.297 and 2.44 mg/mL DBP). To remedy this, different concentrations 
were studied that were below DBP‟s water saturation point (to avoid the physical 
toxicological effects of DBP globules on cells) and above the unresponsive low dose. 
4.2.3. Effects of DBP Exposure on R2C Cell Steroid Biosynthesis 
Exposure of R2C cells to DBP resulted in the induction of cortisol production at all exposure 
levels (0.1-10 μg/mL) compared to controls (P < 0.05) (Fig. 3.17). Whilst cortisol production 
does not significantly change between exposed samples the overall trend suggests that 
cortisol production increases with DBP dose (Fig. 3.17). This effect has not been reported 
previously and is particularly significant because Leydig cells are not known to express the 
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necessary enzymes for glucocorticoid synthesis (CYP21 and CYP11B1) (Payne & Hales 
2004). The effects of activating cortisol biosynthesis are likely to be very significant, 
particularly during early growth and development. This is because cortisol is produced from 
the same precursors as testosterone (Fig. 1.6). Therefore, initiating cortisol production could 
starve testosterone biosynthesis of precursors (Fig. 4.4). Glucocorticoids such as cortisol are 
known to have a negative impact on Leydig cell growth and can potentially induce Leydig 
cell apoptosis as well as down regulating steroid biosynthetic enzymes in Leydig cells further 
reducing testosterone production (Gao et al. 2002; Consten et al. 2002; Drake et al. 2009). 
This could result in an overall decrease in serum testosterone which during early 
development could cause genital malformations such as cryptorchidism and hypospadias 
because testosterone is essential for Wolffian duct development and testis descent. 
Progesterone production, on the other hand, does not change significantly (P < 0.05 
compared to control) in response to DBP exposure (Fig. 3.16). This suggests that DBP does 
not affect the early stages of steroidogenesis. However, this could be due to the fact that R2C 
cells are insensitive to both pituitary peptide hormones (e.g. LH) and internal cAMP 
concentration (both of which effect the early stages of steroidogenesis); indeed it has been 
shown that progesterone concentration decreases in cultured mouse MA-10 Leydig tumour 
cells (these cells have their LH stimulation pathway intact) in response to MBP exposure 
(Clewell et al. 2010). Clewell et al (2010) also showed that another phthalate monoester 
(MEHP) causes down regulation of early steroidogenic enzymes (including StAR, CYP11A, 
CYP17), this suggests that DBP (once it has been metabolised to MBP) could also affect the 
early enzymes in the steroidogenesis pathway via interference with LH binding or internal 
cAMP stimulation thus preventing up regulation of these enzymes which could result in 
reduced production of testosterone by Leydig cells (Fig. 4.3). This could be a potential 
mechanism for DBP toxicity. 
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Another possible mechanism of DBP toxicity is its direct inhibition of steroidogenic 
enzymes. Kinetic studies of both human and rat 3β-HSD and 17β-HSD have shown that 
several phthalates (including DBP) directly inhibited these enzymes activity in a 
concentration dependant manner (Yuan et al. 2012). However, Yuan et al (2012) also 
Figure 4.3: Steroidogenesis pathway showing the reduction in StAR, CYP11A, and CYP17 
expression demonstrated by Clewell et al (2010) on the steroidogenic pathway. Enzyme 
catalysis of the steps highlighted in red will be significantly reduced compared to Leydig 
cells under LH stimulation. This will starve the later stages of testosterone synthesis of 
enzymes. This will result in reduced testosterone secretions by Leydig cells. → = active 
enzyme pathways. X    = Pathways with reduced enzyme activity due to the suppression of 
LH stimulation. 
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demonstrated that the monoester metabolites of these phthalates (e.g. MBP) had little or no 
effect on enzyme catalysis (e.g. MBP had no effect on human 17β-HSD even at mM 
concentrations). Therefore, it is unlikely that direct steroidogenic enzyme inhibition is a 
possible mechanism since DBP is extensively and rapidly metabolised by esterases to MBP 
in vivo (Hanioka et al. 2012; Fennell et al. 2004) (Fig. 1.10). 
The data discussed above suggests a new mechanism of toxicity for DBP, since cortisol 
synthesis uses the same metabolic precursors as testosterone synthesis an increase in cortisol 
synthesis could result in a decrease in testosterone synthesis (Fig. 4.4) (this mechanism of 
toxicity would be augmented if metabolic precursor (e.g. progesterone) biosynthesis is 
slowed by DBP interfering with LH stimulation as observed in Clewell et al‟s (2010) study). 
This change in metabolic flux might result in an overall decrease in circulating testosterone 
levels. In addition, glucocorticoids have been shown to cause negative effects on Leydig cell 
development and are known to induce apoptosis in Leydig cells (Gao et al. 2002; Consten et 
al. 2002). Glucocorticoids have also been shown to decrease androgen production and even 
amplify the effects of phthalates on male reproductive development (Drake et al. 2009; 
Consten et al. 2002) and thus further reduce testosterone synthesis. This could result in a 
feedback mechanism where DBP induces cortisol synthesis and that, in turn, amplifies DBPs 
effect further reducing testosterone synthesis. This increase in cortisol biosynthesis must be 
caused by up-regulation of the enzymes CYP11B and CYP21 by DBP as these enzymes are 
essential for glucocorticoid synthesis and are not normally expressed in Leydig cells (Fig. 
4.4). This is supported by recent data showing that R2C cell‟s testosterone production is 
decreased by DBP in a dose dependant manner (Balbuena et al. 2013). Because R2C cells are 
not stimulated by LH (as well as other pituitary peptide hormones) reductions in LH 
stimulation will not cause a testosterone decrease. This means the only possible mechanisms 
of toxicity must influence enzyme activity in other ways, potentially via cortisol biosynthesis. 
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A combination of these mechanisms of toxicity could explain how exposure to DBP (and 
other phthalates) would result in decreased serum testosterone levels. As testosterone is vital 
for development of the Wolffian duct, external genitalia, and descent of the testis, this would 
explain how direct in utero phthalate exposure might result in developmental defects such as 
cryptorchidism and hypospadias (Parks et al. 2000; Howdeshell et al. 2007; Howdeshell et al. 
Figure 4.4: Steroidogenesis pathway showing the effect of elevated cortisol biosynthesis 
on the steroidogenic flux in Leydig cells. Elevated cortisol biosynthesis will result in the 
starvation of precursors for androgen biosynthetic processes. ►=Stimulated cortisol 
biosynthetic metabolic steps --→ = Androgen biosynthetic processes that will compete for 
precursors. 
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2008; Foster et al. 2000). However, it has recently been shown that the children of New 
Zealand soldiers exposed to high levels of DBP during their service in the Malayan 
Emergency have a higher incidence of cryptorchidism and hypospadias than the general 
population (Carran & Shaw 2010; Carran & Shaw 2012), this suggests that DBP‟s effects are 
multigenerational. This in turn, suggests that DBP mediated toxicity is via an epigenetic gene 
regulatory mechanism because direct exposure of the developing embryo to DBP in this case 
is impossible. This means that maternal DBP exposure could have direct effects on the 
developing embryo‟s expression of genes coding for steroidogenic enzymes (if exposure 
occurs during pregnancy as in most rat based studies (Parks et al. 2000; Howdeshell et al. 
2007; Howdeshell et al. 2008; Foster et al. 2000)) or the epigenetically-mediated changes 
could be inherited via the ovum. However, paternal DBP exposure can only be passed to the 
offspring by epigenetic changes in steroidogenic enzyme expression inherited via the sperm. 
Paternal epigenetic inheritance is known to influence an offspring‟s phenotype (Curley et al. 
2011). For example, the EDC BPA has been shown to have multigenerational epigenetic 
effects via alterations in DNA methylation patterns in multiple mouse models (Dolinoy 2008; 
Kundakovic et al. 2013). These alterations have been shown to cause estrogenic effects 
(Kundakovic et al. 2013). DBP could be inducing an epigenetic effect analogous to this. In 
another study it was shown that a similar effect occurred in rats exposed to a mixture of BPA, 
DBP, and DEHP (Manikkam et al. 2013). This suggests that DBP might induce an epigenetic 
change in the sperm that could be transferred to the developing embryo resulting in 
reproductive defects such as cryptorchidism and hypospadias. 
An important question to ask is, are these effects likely to occur in the general population? 
This is difficult to determine because MBP levels in human serum have not been 
quantitatively measured. The lowest DBP exposure level that initiated cortisol synthesis was 
approximately 0.36 μM (0.1 μg/mL) and the lowest MBP doses that induced a decrease in 
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steroidogenesis as shown by Balbuena et al (2013) (showed a testosterone decrease in R2C 
cells) and Clewell et al (2010) (showed a decrease of LH stimulation in MA-10 cells) were 1 
μM and 3 μM respectively. The European Food Safety Authority found that adults in 
Denmark were exposed to dietary DBP doses of 4.1 μg/kg body weight/day (EFSA 2005). 
Assuming that the average male weighs about 70kg, has 3.3L of serum and 100% absorption 
the final serum concentration is 0.3μM. However, before entering the serum DBP is rapidly 
and completely metabolised to MBP which has been shown in humans to have a conversion 
rate of 69% (Anderson et al. 2001) and is completely absorbed into the circulatory system 
due to its low volume of distribution (Kremer et al. 2005). This would mean that there will be 
a total serum concentration of approximately 0.2 μM. However, all of the MBP will not enter 
the serum simultaneously and using this calculation for the average rat (weight of 400 g and 
64 mL/kg serum) being dosed with 100 mg/kg body weight DBP this calculation suggests 
that the total serum levels of MBP should be 1.5 mM. But, pregnant dams given a 
radiolabelled dose of DBP had an average peak MBP serum level of 329 μM as well as their 
fetus having an average peak dose of 182 μM an order of magnitude lower than the calculated 
concentration. On top of this MBP will also be glucuronidated and human urine studies have 
shown that of a total urine MBP concentration of 29.7 mg/L only 1.4 mg/L was free MBP the 
rest was glucuronidated (Silva et al. 2003). This means that the DBP and MBP concentrations 
in the in vitro studies above are likely much higher than what the general population is 
exposed to. However, this does not mean that the phthalate doses the general population are 
exposed to will not have an effect. Swan et al. (2005) found that AGD decreased in 
correlation with increased prenatal phthalate exposure and that ¼ of the American female 
population were above the median phthalate levels associated with decreased AGD and 
increased cryptorchidism. This suggests that environmental levels of phthalates do have an 
impact on reproductive development. It has also been suggested that phthalates are acting in 
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tandem with other anti-androgenic and estrogenic EDCs that act through a variety of 
mechanisms but all influence the androgen-estrogen ratio causing an overall decrease in 
serum testosterone and an increased incidence of male developmental disorders such as 
cryptorchidism (Toppari et al. 2006). There are also groups who are exposed to elevated 
doses of phthalates through their work. A cohort of construction workers regularly exposed to 
high levels of DBP and DEHP had much higher urine concentrations of MBP and MEHP and 
significantly lower free testosterone concentration compared to unexposed construction 
workers (Pan et al. 2006). Another example would be the Malayan Emergency veterans 
studied by Carran & Shaw (2012) who were exposed to a theoretical dose above the no 
observable adverse effect level (NOAEL). These groups are more likely to have serum levels 
that equate to the DBP and MBP concentrations used in in vitro studies and are therefore 
more likely to have similar alterations in their Leydig cell‟s steroid production (i.e. decreased 
testosterone production and increased cortisol production). 
In conclusion DBP causes an increase in cortisol production in R2C Leydig cells. This could 
alter the steroidogenic flux toward cortisol and away from testosterone. The cortisol produced 
could then adversely affect Leydig cell development further decreasing testosterone 
production. If this mechanism occurs in vivo along with the previously documented ability of 
DBP to inhibit LH stimulation this could explain how DBP exposure leads to male 
developmental defects such as cryptorchidism and hypospadias. 
4.3 Future Work 
To further support this hypothesis, further studies could be performed with both R2C and LC-
540 cell lines using the much more hormone specific radioimmunoassay technique. This 
would produce much more accurate steroid media level data and will eliminate background 
noise caused my other compounds found in the media extract. DB-cAMP‟s effect on LC-540 
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steroidogenesis could be looked at in more depth to determine whether the LC-540 cell line 
has the early regulatory mechanisms for steroidogenesis seen in wild type Leydig cells. The 
LC-540 cell line could be used in similar experiments to the R2C cell line. Because it can 
produce quantifiable levels of testosterone it could be used to compare cortisol and 
testosterone production during DBP exposure. CYP21, CYP11B, and 17β-HSD expression 
could also be measured to show if the cortisol synthesising enzymes (CYP11B and CYP21) 
are up regulated and if 17β-HSD (an enzyme used exclusively for androgen and estrogen 
synthesis) is down regulated. 
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